{"doi":null,"coreId":"12407","oai":"oai:wrap.warwick.ac.uk:34601","identifiers":["oai:wrap.warwick.ac.uk:34601",null],"title":"The potential of a novel Adenovirus vector for vaccination","authors":["Martin, Stuart"],"enrichments":{"references":[{"id":37505654,"title":"A","authors":[],"date":"2006","doi":null,"raw":"Stone, D, & Lieber, A (2006). New serotypes of adenoviral vectors. Curr. Opin. Mol. Ther. 8, 423\u2013431.","cites":null},{"id":37505434,"title":"A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture.","authors":[],"date":"1992","doi":null,"raw":"Brown, M., Wilson-Friesen, H.L. & Doane, F. (1992) A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture. J. Virol. 66, 3198-3205 Buchbinder, S.P., Mehrotra, D.V., Duerr, A., Fitzgerald, D.W., Mogg, R., Li, D., Gilbert, P.B., Lama, J.R., Marmor, M., Del Rio, C., McElrath, M.J., Casimiro, D.R., Gottesdiener, K.M., Chodakewitz, J.A., Corey, L. & Robertson, M.N. (2008).","cites":null},{"id":37505610,"title":"A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.","authors":[],"date":"1995","doi":null,"raw":"A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J. Gen. Virol. 85, 911-919 Nagata, S. & Golstein, P. (1995) The Fas death factor. Science 10, 1449-1456 Nalbantoglu, J., Pari, G., Karpati, G. & Holland, P. C. (1999).Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum. Gene Ther. 10, 1009\u20131019.","cites":null},{"id":37505668,"title":"A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.","authors":[],"date":"2006","doi":null,"raw":"Tuve, S., Wang, H., Ware, C., Liu, Y., Gaggar, A., Bernt, K., Shayakhmetov, D., Li, Z., Strauss, R., Stone, D. & Lieber, A. (2006) A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J. Virol. 80, 12109-12120 Tuve, S., Wang, H., Jacobs, J.D., Yumul, R.C., Smith, D.F. & Lieber, A. (2008) Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog. e1000189 Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J.W., Pascual, V., Palucka, A.K. & Banchereau, J. (2007) Dendritic cell subsets in health and disease. Immunol. Rev. 219, 118\u2013142 Ueno, H., Schmitt, N., Klechevsky, E., Pedroza-Gonzalez, A., Matsui, T., Zurawski, G., Oh, S., Fay, J., Pascual, V., Banchereau, J. & Palucka, K. (2010) Harnessing human dendritic cell subsets for medicine. Immunol. Rev. 234, 199-212 Ulasov, I.V., Tyler, M.A., Zheng, S., Han, Y. & Lesniak, M.S. (2006) CD46 represents a target for adenoviral gene therapy of malignant glioma. Hum. Gene Ther. 17, 556-564 Ugai, H., Yamasaki, T., Hirose, M., Inabe, K., Kujime, Y., Terashima, M., Liu, B., Tang, H., Zhao, M., Murata, T., Kimura, M., Pan, J., Obata, Y., Hamada, H. & Yokyama, K.K. (2005) Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration. Biochem. Biophys. Res. Commun 14, 1053-1060 Ulloa, F. & Real, F.X. (2001) Differential distribution of Sialic Acid in \u03b12,3 and \u03b12,6 linkages in the apical membrane of cultured epithelial cells and tissues. J. Histochem. Cytochem. 49, 501-509 Ustacelebi, S. & Williams, J.F. (1972) Temperature-sensitive mutants of adenovirus defective in interferon induction at non-permissive temperature. Nature 235, 52\u201353 Valarcher, J.F. & Taylor, G. (2007) Bovine respiratory syncitial virus infection. Vet. Res. 38, 153-180 Valentin, A., Albert, J., Fenyo, E. M. & Asjo, B. (1994) Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68, 6684\u20136689 Varki, A. (2008) Sialic acids in human health and disease. Trends Mol. Med. 14, 351-360 Varnavski, A.N., Schlienger, K., Bergelson, J.M., Gao, G.P. & Wilson, J.M. (2003) Efficient transduction of human monocyte-derived dendritic cells by chimpanzeederived adenoviral vector. Hum. Gene Ther. 14, 533-544 Vasu, C., Wang, A., Gorla, S.R., Kaithamana, S., Prabhakar, B.S. & Holterman, M.J. (2003) CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties. Int. Immunol. 15, 167\u2013175.","cites":null},{"id":37505728,"title":"A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.","authors":[],"date":"1996","doi":null,"raw":"Xiang, Z.Q., Yang, Y., Wilson, J.M. & Ertl, H.C. (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227 Yamaguchi, T., Kawabata, K., Koizumi, N., Sakurai, F., Nakashima, K., Sakurai, H., Sasaki, T., Okada, N., Yamanishi, K. & Mizuguchi, H. (2007) Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum.","cites":null},{"id":37505437,"title":"Adenoviral keratoconjunctivitis in a tertiary care eye clinic,","authors":[],"date":"2006","doi":null,"raw":"Butt, A.L. & Chodosh, J. (2006) Adenoviral keratoconjunctivitis in a tertiary care eye clinic, Cornea 25, 199\u2013202.","cites":null},{"id":37505652,"title":"Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigenspecific cellular IFN-gamma and antibody responses in mice.","authors":[],"date":"2008","doi":null,"raw":"Virus Res. 122, 144-153 Shott, J.P., McGrath, S.M., Pau, M.G., Custers, J.H., Ophorst, O., Demoiti\u00e9, M.A., Dubois, M.C., Komisar, J., Cobb, M., Kester, K.E., Dubois, P., Cohen, J., Goudsmit, J., Heppner, D.G. & Stewart, V.A. (2008) Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigenspecific cellular IFN-gamma and antibody responses in mice. Vaccine 26, 2818-2823 Siddiqui, S.S., Aamodt, E., Rastineiad, F. & Culotti, J. (1989) Anti-tubulin monoclonal antibodies that bind to specific neurons in Caenorhabditis elegans. J. Neurosci. 9, 2963-2972 Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., Ho, S., Antonenko, S. & Liu YJ. (1999) The nature of the principal type 1 interferonproducing cells in human blood. Science 284, 1835-1837 Sirena, D., Lilienfeld, B., Eisenhut, M., K\u00e4lin, S., Boucke, K., Beerli, R.R., Vogt, L., Ruedl, C., Bachmann, M.F., Greber, U.F. & Hemmi, S. (2004) The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J. Virol. 78, 4454-4462 Slager, E.H.., van der Minne, C.E., Goudsmit, J., van Oers, J.M., Kostense, S., Havenga, M.J., Osanto, S. & Griffioen, M. (2004) Induction of CAMEL\/NY-ESOORF2-specific CD8+ T cells upon stimulation with Dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5\/35 fibre. Cancer Gene Ther. 11, 227-236 Smith, T.A., Idamakanti, N., Marshall-Neff, J., Rollence, M.L., Wright, P., Kaloss, M., King, L., Mech, C., Dinges, L., Iverson, W.O., Sherer, A.D., Markovits, J.E., Lyons, R.M., Kaleko, M. & Stevenson, S.C. (2003) Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum. Gene Ther. 14, 1595-1604 Smith, C.A., Woodruff, L.S., Rooney, C. & Kitchingman, G.R. (1998) Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum. Gene Ther. 9, 1419-1427 Smyth, R.L. & Openshaw, P.J. (2006) Bronchiolitis. Lancet 368, 312\u201322 Southern, J.A., Young, D.F., Heaney, F., Baumg\u00e4rtner, W.K. & Randall, R.E. (1991) Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics. J. Gen. Virol. 72, 1551-1557 Springer, G.F., Schwick, H.G. & Fletcher, M.A. (1969) The relationship of the influenza virus inhibitory activity of glycoproteins to their molecular size and sialic acid content. PNAS 64, 634-641 Stanley, P., Caillibot, V. & Siminovitch, L. (1975) Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell. J. Immunol. 91, 416-424 Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. & Enk, A.H. (1997) Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159, 4772\u20134780 Steinman, R.M. & Banchereau, J. (2007) Taking dendritic cells into medicine. Nature 449, 419-426 Steinman, R.M. & Hemmi, H. (2006) Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311, 17-58 Steinwaerder, D.S., Carlson, C.A. & Lieber, A. (1999) Generation of adenovirus vectors devoid of all genes by recombination between inverted repeats. J. Virol. 73, 9303-9313 Stewart, P.L. & Nemerow, G.R. (2007) Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol. 15, 500\u2013507.","cites":null},{"id":37505507,"title":"Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.","authors":[],"date":"2010","doi":null,"raw":"Granio, O., Ashbourne Excoffon, K.J., Henning, P., Melin, P., Norez, C., Gonzalez, G., Karp, P.H., Magnusson, M.K., Habib, N., Lindholm, L., Becq, F., Boulanger, P., Zabner, J. & Hong, S.S. (2010) Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia. Hum. Gene Ther. 21, 251-169 Granio, O., Porcherot, M., Corjon, S., Kitidee, K., Henning, P., Eljaafari, A., Cimarelli, A., Lindholm, L., Miossec, P., Boulanger, P. & Hong, S.S. (2009) Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus. Hum.","cites":null},{"id":37505574,"title":"Adenovirus E3\/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A","authors":[],"date":"2008","doi":null,"raw":"Br. Med. Bull. 62, 87-98 McSharry, B.P., Burgert, H-G., Owen, D.P., Stanton, R.J., Prod'homme, V., Sester, M., Koebernick, K., Groh, V., Spies, T., Cox, S., Little, A.M., Wang, E.C., Tomasec, P. & Wilkinson, G.W. (2008) Adenovirus E3\/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J. Virol. 82, 4585-4594 McVey, D., Zuber, M., Ettyreddy, D., Brough, D.E. & Kovesdi, I. (2002). Rapid construction of adenoviral vectors by lambda phage genetics. J. Virol.76, 3670\u20133677.","cites":null},{"id":37505678,"title":"Adenovirus fibre disrupts CAR-mediated intercellular adhesion allowing virus escape.","authors":[],"date":"2002","doi":null,"raw":"Walters, R.W., Freimuth, P., Moninger, T.O., Ganske, I., Zabner, J. & Welsh, M.J. (2002) Adenovirus fibre disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110, 789\u2013799.","cites":null},{"id":37505642,"title":"Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.","authors":[],"date":"1953","doi":null,"raw":"Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J. Exp. Med. 202, 1477-1482 Rowe, W., Huebner, R., Gilmore, L., Parrott, R., & Ward, T. (1953). Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 84, 570-573.","cites":null},{"id":37505631,"title":"Adenovirus type 11 binding alters the conformation of its receptor CD46.","authors":[],"date":"2007","doi":null,"raw":"& Stehle, T. (2007) Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat. Struct. Mol. Biol. 14, 164-166 Pierre, P., Turley, S.J., Gatti, E., Hull, M., Meltzer, J., Mirza, A., Inaba, K., Steinmann, R.M. & Mellman, I. (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-92 Pinto, A.R., Fitzgerald, J.C., Gao, G.P., Wilson, J.M. & Ertl, H.C. (2004) Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector. Vaccine 22, 697-703 Priddy, F.H., Brown, D., Kublin, J., Monahan, K., Wright, D.P., Lalezari, J., Santiago, S., Marmor, M., Lally, M., Novak, R.M., Brown, S.J., Kulkarni, P., Dubey, S.A., Kierstead, L.S., Casimiro, D.R., Mogg, R., DiNubile, M.J., Shiver, J.W., Leavitt, R.Y., Robertson, M.N., Mehrotra, D.V., Quirk, E. & Merck V520-016 Study Group. (2008) Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults. Clin. Infect. Dis. 46, 1769-1781 Pringle, C.R. & Eglin, R.P. (1986). Murine pneumonia virus: seroepidemiological evidence of widespread human infection. J. Gen. Virol. 67, 975\u2013982 Puck, T.T., Cieciura, S.J. & Fisher, H.W. (1958) Clonal growth in vitro of human cells with fibroblastic morphology. J. Exp. Med. 108, 945 Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R. & Pulendran, B. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413\u2013424 Radosevi\u0107, K., Wieland, C.W., Rodriguez, A., Weverling, G.J., Mintardjo, R., Gillissen, G., Vogels, R., Skeiky, Y.A., Hone, D.M., Sadoff, J.C., van der Poll, T., Havenga, M. & Goudsmit, J. (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect. Immun. 75, 4106-4115 Rambaut, A., Posada, D., Crandall, K.A. & Holmes, E.C. (2004) The causes and consequences of HIV evolution. Nat. Rev. Genet. 5, 52-61 Ranieri, E., Herr, W., Gambotto, A., Olson, W., Rowe, D., Robbins, P.D., Kierstead, L.S., Watkins, S.C., Gesualdo, L. & Storkus, W.J. (1999) Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J. Virol. 73, 10416-10425 Raper, S.E., Chirmule, N., Lee, F.S., Wivel, N.A., Bagg, A., Gao, G.P., Wilson, J.M. & Batshaw, M.L. (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol.","cites":null},{"id":37505526,"title":"Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells.","authors":[],"date":"1997","doi":null,"raw":"Immunol. Today 13, 231-236 Hong, S.S., Karayan, L., Tournier, J., Curiel, D.T. & Boulanger, P.A. (1997) Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO 16, 2294-2306 Hopps, H.E., Bernheim, B.C., Nisalak, A., Tjio, J.H. & Smadel, J.E. (1963) Biologic characteristics of a continuous kidney cell line derived from the African Green Monkey. J. Immunol. 91, 416-424 Hsu, C., Boysen, M., Gritton, L.D., Frosst, P.D., Nemerow, G.R. & Von Seggern D.J. (2005) In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity. Virology 332, 1\u20137 Huang, S., Endo, R.I. & Nemerow, G.R. (1995) Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69, 2257-2263 Huang, S., Kamata, T., Takada, Y., Ruggeri, Z.M. & Nemerow, G.R. (1996) Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70, 4502-4508 Huang, X. & Yang, Y. (2009) Innate immune recognition of viruses and viral vectors. Hum. Gene Ther. 20, 293-301 Huebner, R., Rowe, W., Ward, T., Parrott, R., & Bell, J. (1954). Adenoidalpharyngeal-conjunctival agents: a newly recognised group of common viruses of the respiratory system. N. Engl. J. Med. 251, 1077-1086 Hutchin, M.E., Pickles, R.J. & Yarbrough, W.G. (2000). Efficiency of adenovirusmediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum. Gene Ther. 11, 2365\u20132375 Hutnick, N.A., Carnathan, D., Demers, K., Makedonas, G., Ertl, H.C. & Betts, M.R. (2010) Adenovirus-specific human T cells are pervasive, polyfunctional, and crossreactive. Vaccine 28, 1932-1941 Iacobelli-Martinez, M. & Nemerow, G.R. (2007) Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J. Virol. 81, 1305-1312 Im, E.J. & Hanke, T. (2007) Preclinical Evaluation of Candidate HIV Type 1 Vaccines in Inbred Strains and an Outbred Stock of Mice. AIDS Res. Hum. Ret. 23, 857-862 Imperiale, M. J. & Kochanek, S. (2004). Adenovirus vectors: biology, design, and production. Curr. Top. Microbiol. Immunol. 273, 335-357 Ishiko, H. & Aoki, K. (2009) Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan. J. Clin. Microbiol. 47, 2678-2679 Jaoko, W., Nakwagala, F.N., Anzala, O., Manyonyi, G.O., Birungi, J., Nanvubya, A., Bashir, F., Bhatt, K., Ogutu, H., Wakasiaka, S., Matu, L., Waruingi, W., Odada, J., Oyaro, M., Indangasi, J., Ndinya-Achola, J., Konde, C., Mugisha, E., Fast, P., Schmidt, C., Gilmour, J., Tarragona, T., Smith, C., Barin, B., Dally, L., Johnson, B., Muluubya, A., Nielsen, L., Hayes, P., Boaz, M., Hughes, P., Hanke, T., McMichael, A., Bwayo, J. & Kaleebu, P. (2008) Safety and immunogenicity of recombinant lowdosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. Vaccine 26, 2788-2795 Javier, R.T. (1994). Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats. J. Virol. 68, 3917-3924 Jawetz, E., Hanna, L., Sonne, M. & Thygeson, P. (1959). A laboratory infection with adenovirus type 8. Am. J. Hyg. 69, 13-20.","cites":null},{"id":37505479,"title":"Adenovirus type 5 pseudotyped with adenovirus type 37 fibre uses sialic acid as a cellular receptor.","authors":[],"date":"2004","doi":null,"raw":"Cashman, S.M., Morris, D.J. & Kumar-Singh, R. (2004) Adenovirus type 5 pseudotyped with adenovirus type 37 fibre uses sialic acid as a cellular receptor. Virology 324, 129\u2013139.","cites":null},{"id":37505415,"title":"Adenovirus type37 binds to cell surface sialic acid through a chargedependent interaction. Virology 302, 33\u201343","authors":[],"date":"2002","doi":null,"raw":"(2002) Adenovirus type37 binds to cell surface sialic acid through a chargedependent interaction. Virology 302, 33\u201343 bArnberg, N., Kidd, A.H., Edlund, K., Olfat, F. & Wadell, G. (2000) Initial interactions of subgenus D adenoviruses with A549 cellular receptors: Sialic acid versus \u03b1v integrins. J. Virol. 74, 7691-7693 Arnberg, N., Mei, Y. & Wadell, G. (1997) Fibre genes of adenoviruses with tropism for the eye or genital tract. Virology 6, 239-244 Arnberg, N., Pring-Akerblom, P. & Wadell, G. (2002) Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J. Virol. 76, 8834-8841 Avery, R.M., Shelton, A.P., Beards, G.M., Omotade, O.O., Oyejide, O.C. & Olaleye, D.O. (1992) Viral agents associated with infantile gastroenteritis in Nigeria: Relative prevalence of adenovirus serotypes 40 and 41, astrovirus, and rotavirus serotypes 1 to 4. J. Diarrhoeal. Dis. Res. 10, 105\u2013108.","cites":null},{"id":37505633,"title":"Adenoviruses activate human dendritic cells without polarisation toward a T helper type 1 inducing subset.","authors":[],"date":"1999","doi":null,"raw":"Genet. Metab. 80, 148-158 Rea, D., Schagen, F.H.E., Hoeben, R.C., Mehtali, M., Havenga, M.J.E., Toes, R.E.M., Melief, C.J.M. & Offringa, R. (1999) Adenoviruses activate human dendritic cells without polarisation toward a T helper type 1 inducing subset. J. Virol. 73, 10245-10257 Rea, D., Havenga, M.J.E., van der Assam, M., Sutmuller, R.P.M., Lemckert, A., Hoeben, R.C., Bout, A., Melief, C.J.M. & Offringa, R. (2001) Highly efficient transduction of Human Monocyte-derived dendritic cells with subgroup B modified Adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J. Immunol. 166, 5236-5244 Reddy, P.S., Idamakanti, N., Chen, Y., Whale, T., Babiuk, L.A., Mehtali, M. & Tikoo, S.K. (1999) Replication-defective bovine adenovirus type 3 as an expression vector. J. Virol. 73, 9137\u20139144.","cites":null},{"id":37505495,"title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.","authors":[],"date":"1994","doi":null,"raw":"Crystal, R.G., McElvaney, N.G., Rosenfeld, M.A., Chu, C.S., Mastrangeli, A., Hay, J.G., Brody, S.L., Jaffe, H.A., Eissa, N.T. & Danel, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42-51 Cupelli, K., M\u00fcller, S., Persson, B.D., Jost, M., Arnberg, N. & Stehle, T. (2010) Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses. J. Virol. 84, 3189-3200 Custom Adenovirus service FAQ: Vector Biolabs. Vector Biolabs. Available from: http:\/\/www.vectorbiolabs.com\/vbs\/faq-product.html Czerkinsky, C., Nilsson, L., Nygren, H., Ouchterlony, O. & Tarkowski, A. (1983) A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65, 109\u2013121 Davison, A.J., Benko, M. & Harrach, B. (2003). Genetic content and evolution of adenoviruses. J. Gen. Virol. 84, 2895-908 Davison, E., Kirby, I., Elliott, T. & Santis, G. (1999) The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. J. Virol. 73, 4513-4517 Dawson, C., Jawetz, E., Hanna, L., Winn, W.E.T. & Thompson, C. (1960). A family outbreak of adenovirus 8 infection (epidemic keratoconjunctivitis). Am. J. Hyg. 72, 279-283.","cites":null},{"id":37505439,"title":"An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens.","authors":[],"date":"1985","doi":null,"raw":"Burgert, H-G., & Kvist, S. (1985). An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41, 987-97.","cites":null},{"id":37505762,"title":"An efficient recombination system for chromosome engineering in Escherichia coli PNAS.","authors":[],"date":"2000","doi":null,"raw":"Yu, D., Ellis, H.M., Lee, E.C., Jenkins, N.A., Copeland, N.G. & Court, D.L. (2000) An efficient recombination system for chromosome engineering in Escherichia coli PNAS. 97, 5978\u20135983 Zhang, Y., Buchholz, F., Muyrers, J.P. & Stewart, A.F. (1998). A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 20, 123\u2013128 Zhang, Y., Chirmule, N., Gao, G.P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J. & Wilson, J.M. (2001) Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 3, 697-707 Zhang, Y., Muyrers, J.P., Testa, G. & Stewart, A.F. (2000). DNA cloning by homologous recombination in Escherichia coli. Nat. Biotechnol. 18, 1314\u2013 1317 Zheng, X., Vladau, C., Shunner, A. & Min, W.P. (2010) siRNA specific system for targeting dendritic cells. Methods Mol. Biol. 623, 173-188 Zhong, L., Granelli-Piperno, A., Choi, Y. & Steinmann, R.M. (1999) Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol 29, 964-972 Zhong, Z., Shi, S., Han, J., Zhang, Z. & Sun, X. (2010) Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells. Mol. Pharm. 7, 105-115 Zhou, H., O\u2019Neal, W., Morral, N. & Beaudet, A.L. (1996) Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. J. Virol. 70, 7030-7038 Zhu, J., Huang, X. & Yana, Y. (2008) A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Mol. Ther. 16, 1300-1307","cites":null},{"id":37505618,"title":"Avian influenza and sialic acid receptors: more than meets the eye? Lancet Infect.","authors":[],"date":"2005","doi":null,"raw":"Eur. J. Immunol. 36, 2585-2594 Olofsson, S., Kumlin, U., Dimock, K. & Arnberg, N. (2005) Avian influenza and sialic acid receptors: more than meets the eye? Lancet Infect. Dis. 5, 184-188 Olszewska, W. & Openshaw, P. (2009) Emerging drugs for Respiratory Syncitial Virus infection Expert Opin. Emerg. Drugs 14, 207-217 Ophorst, O.J., Radosevi\u0107, K., Havenga, M.J., Pau, M.G., Holterman, L., Berkhout, B., Goudsmit, J. & Tsuji, M. (2006) Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect. Immun. 74, 313-320 Ozato, K., Mayer, N.M. & Sachs, D.H.  (1982).  Monoclonal Antibodies to mouse major histocompatibility complex antigens.  Transplantation 34, 113-120.","cites":null},{"id":37505676,"title":"Basolateral localization of fibre receptors limits adenovirus infection from the apical surface of airway epithelia.","authors":[],"date":"1999","doi":null,"raw":"(1999) Basolateral localization of fibre receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274, 10219\u201310226.","cites":null},{"id":37505426,"title":"Binding of adenovirus capsid to dipalmitoylphosphatidylcholine provides a novel pathway for virus entry.","authors":[],"date":"2003","doi":null,"raw":"Balakireva, L., Schoehn, G., Thouvenin, E. & Chroboczek, J. (2003) Binding of adenovirus capsid to dipalmitoylphosphatidylcholine provides a novel pathway for virus entry. J. Virol. 77, 4858-4866 Banchereau, J., Klechevsky, E., Schmitt, N., Morita, R., Palucka, K. & Ueno, H.","cites":null},{"id":37505508,"title":"Biochemical studies on Adenovirus multiplication. XIII. Plaquing efficiencies of purified human adenoviruses.","authors":[],"date":"1967","doi":null,"raw":"Gene Ther.83, 6048-6066 Green, M., Pina, M. & Kimes, R.C. (1967) Biochemical studies on Adenovirus multiplication. XIII. Plaquing efficiencies of purified human adenoviruses. Virology 3, 562-565 Greig, J.A., Buckley, S.M., Waddington, S.N., Parker, A.L., Bhella, D., Pink, R., Rahim, A.A., Morita, T., Nicklin, S.A., McVey, J.H. & Baker, A.H. (2009) Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5\/Ad35 vectors. Mol. Ther. 10, 1683-1691 Groux, H., Fournier, N. & Cottrez, F. (2004) Role of dendritic cells in the generation of regulatory T cells. Semin. Immunol. 16, 99-106 Guimar\u00e3es-Walker, A., Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., Barin, B., McMichael, A., Weber, J., Legg, K., Babiker, A., Hayes, P., Gotch, F., Smith, C., Dally, L., Dorrell, L., Cebere, I., Kay, R., Winstone, N., Moore, S., Goonetilleke, N., Fast, P. & IAVI-006 Study Group. (2008) Lessons from IAVI006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. Vaccine 26, 6671-6677 Haigwood, N.L., Watson, A., Sutton, W.F., McClure, J., Lewis, A., Ranchalis, J., Travis, B., Voss, G., Letvin, N.L., Hu, S.L., Hirsch, V.M. & Johnson, P.R. (1996) Passive immune globulin therapy in the SIV\/macaque model: early intervention can alter disease profile. Immuno. Let. 51, 107-114 Haj-Ahmad, Y. & Graham, F.L. (1986) Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J. Virol. 57, 267-274 Hallak, L.K., Spillmann, D., Collins, P.L. & Peeples, M.E. (2000) Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.","cites":null},{"id":37505505,"title":"Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state.","authors":[],"date":"2007","doi":null,"raw":"& Merad, M. (2007) Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204, 3133\u20133146 Gooding, L., Sofola, I., Tollefson, A., Duerksen-Hughes, P., & Wold, W. (1990). The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factormediated cytolysis. J. Immunol. 145, 3080-3086.","cites":null},{"id":37505663,"title":"by Adenovirus Proteins.","authors":[],"date":"2001","doi":null,"raw":"Tollefson, A.E., Toth, K., Doronin, K., Kuppuswamy, M., Doronina, O.A., Lichtenstein, D.L., Hermiston, T.W., Smith, C.A. &Wold, W.S.M. (2001). Inhibition of TRAIL-Induced Apoptosis and Forced Internalisation of TRAIL Receptor 1 by Adenovirus Proteins. J. Virol. 75, 8875-8887.","cites":null},{"id":37505687,"title":"Characterization of E3\/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.","authors":[],"date":"2002","doi":null,"raw":"Windheim, M. & Burgert, H-G. (2002) Characterization of E3\/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a. J. Virol. 76, 755-766 Windheim, M., Hilgendorf, A. & Burgert, H-G. (2004) Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways. Curr. Top.","cites":null},{"id":37505543,"title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","authors":[],"date":"1970","doi":null,"raw":"Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 Larke, N., Murphy, A., Wirblich, C., Teoh, D., Estcourt, M.J., McMichael, A.J., Roy, P. & Hanke, T. (2005). Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J. Virol. 79, 14822\u201314833 Lasaro, M.O. & Ertl, H.C. (2009) New insights on adenovirus as vaccine vectors.","cites":null},{"id":37505541,"title":"Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.","authors":[],"date":"2009","doi":null,"raw":"Jonnson, M.I., lenman, A.E., Fr\u00e4ngsmyr, L., Nyberg, C., Abdullahi, M. & Arnberg, N. (2009) Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells. J. Virol. 83, 3816-3825 Kahn, J.O. & Walker, B.D. (1998). Acute Human Immunodeficiency Virus type 1 infection. N. Engl. J. Med. 331, 33\u201339 Kim, H.W., Canchola, J.G., Brandt, C.D., Pyles, G., Chanock, R.M., Jensen, K., Parrott, R.H. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422-434 King, M.Q., Stott, E.J., Langer, S.J., Young, K.K.-Y., Ball, L.A. & Wertz, G.W. (1987) Recombinant vaccinia virus carrying the N gene of Human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. J. Virol. 61, 2885\u20132890 Kojaoghlanian, T., FlomenBerk, P. & Horwitz, M.S. (2003). The Impact of Adenovirus infection on the immunocompromised host. Rev. Med. Virol. 13, 155-171 Komada, Y., Inaba, H., Li, Q., Azuma, E., Zhan, Y.W., Yamamoto, H. & Sakurai, M. (1999). Epitopes of functional responses defined by a panel of anti-Fas (CD95) monoclonal antibodies. Hybridoma 18, 391-398 Kreppel, F. & Kochanek, S. (2008). Modification of adenovirus gene transfer vectors with synthetic polymers: A scientific review and technical guide. Mol. Ther. 16, 16\u2013 Kusumi, K., Conway, B., Cunningham, S., Berson, A., Evans, C., Iversen, A.K., Colvin, D., Gallo, M.V., Coutre, S., Shpaer, E.G., Faulkner, D.V., DeRonde, A.,Volkman, S., Williams, C., Hirsch, M.S. & Mullins, J.I. (1992) Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66, 875-885 Kvist, S., OstBerk, L., Persson, H., Philipson, L., & Peterson, P. (1978). Molecular association between transplantation antigens and cell surface antigen in adenovirustransformed cell line. PNAS 75(11), 5674-8.","cites":null},{"id":37505481,"title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.","authors":[],"date":"2003","doi":null,"raw":"Casimiro, D.R., Chen, L., Fu, T.M., Evans, R.K., Caulfield, M.J., Davies, M.E., Tang, A., Chen, M., Huang, L., Harris, V., Freed, D.C., Wilson, K.A., Dubey, S., Zhu, D.M., Nawrocki, D., Mach, H., Troutman, R., Isopi, L., Williams, D., Hurni, W., Xu, Z., Smith, J.G., Wang, S., Liu, X., Guan, L., Long, R., Trigona, W., Heidecker, G.J., Perry, H.C., Persaud, N., Toner, T.J., Su, Q., Liang, X., Youil, R., Chastain, M., Bett, A.J., Volkin, D.B., Emini, E.A. & Shiver, J.W. (2003) Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77, 6305-6316 Casimiro, D.R., Tang, A., Chen, L., Fu, T.M., Evans, R.K., Davies, M.E., Freed, D.C., Hurni, W., Aste-Amezaga, J.M., Guan, L., Long, R., Huang, L., Harris, V., Nawrocki, D.K., Mach, H., Troutman, R.D., Isopi, L.A., Murthy, K.K., Rice, K., Wilson, K.A., Volkin, D.B., Emini, E.A. & Shiver, J.W. (2003) Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77, 7663-7668.","cites":null},{"id":37505410,"title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups","authors":[],"date":"2007","doi":null,"raw":"Abbink, P., Lemckert, A.A., Ewald, B.A., Lynch, D.M., Denholtz, M., Smits, S., Holterman, L., Damen, I., Vogels, R., Thorner, A.R., O\u2019Brien, K.L., Carville, A., Mansfield, K.G., Goudsmit, J., Havenga, M.J. & Barouch, D.H. (2007). Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81, 4654\u20134663 Adams, W. C., Bond, E., Havenga, M. J., Holterman, L., Goudsmit, J., KarlssonHedestam, G. B., Koup, R. A. & Lore, K. (2009). Adenovirus serotype 5 infects human dendritic cells via a CAR-independent receptor pathway mediated by lactoferrin and DC-SIGN. J. Gen. Virol. 90, 1600\u20131610 Ahlers, J.D. & Belyakov, I.M. (2009) Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol. Med. 15, 263-274 Akbari, O., Panjwani, N., Garcia, S., Tascon, R., Lowrie, D. & Stockinger, B. (1999) DNA vaccination: transfection and activation of Dendritic cells as key events for immunity. J. Exp. Med. 189, 169-178 Alba, R., Bradshaw, A.C., Parker, A.L., Bhella, D., Waddington, S.N., Nicklin, S.A., van Rooijen, N., Custers, J., Goudsmit, J., Barouch, D.H., McVey, J.H. & Baker, A.H. (2009) Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114, 965-971 Albinsson, B. & Kidd, A.H. (1999) Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res. 64, 125-136 Alemany, R. & Curiel, D.T. (2001) CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8, 1347\u20131353 Alper, M.D. & Ames, B.N. (1975) Positive selection of mutants with deletions of the gal-chl region of the Salmonella chromosome as a screening procedure for mutagens that cause deletions J. Bacteriol., 121, 259\u2013266 Andrews, J.L., Kadan, M.J., Gorziglia, M.I., Kaleko, M. & Connelly, S. (2001) Generation and characterization of E1\/E2a\/E3\/E4-deficient adenoviral vectors encoding human factor VIII. Mol. Ther. 3, 329-336 Aoki, K., Ishiko, H., Konno, T., Shimada, Y., Hayashi, A., Kaneko, H., Ohguchi, T., Tagawa, Y., Ohno, S. & Yamazaki, S. (2008). Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37\/H8 human adenovirus. J. Clin. Microbiol. 46, 3259-69 Aoki, K. & Tagawa, Y. (2002) A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int. Opthamol. Clin. 42, 49-54 Appledorn, D.M., Patial, S., McBride, A., Godbehere, S., Van Rooijen, N., Parameswaran, N. & Amalfitano, A. (2008) Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181, 2134-2144 Arnberg, N. (2009) Adenovirus receptors: implications for tropism, treatment and targeting. Rev. Med. Virol. 19, 165-178 aArnberg, N., Edlund, K., Kidd, A.H. & Wadell, G. (2000) Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 74, 42\u201348 Arnberg, N., Kidd, A.H., Edlund, K., Nilsson, J., Pring-\u00c5kerblom, P. & Wadell, G.","cites":null},{"id":37505655,"title":"Comparison of adenoviruses from species B, C, E, and F after intravenous delivery.","authors":[],"date":"2007","doi":null,"raw":"Stone, D., Liu, Y., Li, Z.Y., Tuve, S., Strauss, R. & Lieber, A. (2007) Comparison of adenoviruses from species B, C, E, and F after intravenous delivery. Mol. Ther. 15, 2146-2153.","cites":null},{"id":37505651,"title":"Conserved amino acids within the adenovirus 2 E3\/19K protein differentially affect downregulation of MHC class I and MICA\/B","authors":[],"date":"2010","doi":null,"raw":"Sester, M., Koebernick, K., Owen, D., Ao, M., Bromberg, Y., May, E., Stock, E., Andrews, L., Groh, V., Spies, T., Steinle, A., Menz, B. & Burgert, H-G. (2010) Conserved amino acids within the adenovirus 2 E3\/19K protein differentially affect downregulation of MHC class I and MICA\/B proteins. J. Immunol.184, 255-267 Shashkova, E.V., May, S.M. & Barry, M.A. (2009) Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents. Virology 394, 311-320 Shiver, J.W. & Emini, E.A. (2004) Recent advance in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55, 355-372 Shiver, J.W., Fu, T.M., Chen, L., Casimiro, D.R., Davies, M.E., Evans, R.K., Zhang, Z.Q., Simon, A.J., Trigona, W.L., Dubey, S.A., Huang, L.Y., Harris, V.A., Long, R.S., Liang, X.P., Handt, L., Schleif, W.A., Zhu, L., Freed, D.C., Persaud, N.V., Guan, L., Punt, K.S., Tang, A., Chen, M.C., Wilson, K.A., Collins, K.B., Heidecker, G.J., Fernandez, V.R., Perry, H.C., Joyce, J.G., Grimm, K.M., Cook, J.C., Keller, P.M., Kresock, D.S., Mach, H., Troutman, R.D., Isopi, L.A., Williams, D.M., Xu, Z., Bohannon, K.E., Volkin, D.B., Montefiori, D.C., Miura, A., Krivulka, G.R., Lifton, M.A., Kuroda, M.J., Schmitz, J.E., Letvin, N.L., Caulfield, M.J., Bett, A.J., Youil, R., Kaslow, D.C., & Emini, E.A. (2002) Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331-335 Shayakhmetov, D.M., Gaggar, A., Ni, S., Li, Z-Y. & Lieber, A. (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79, 7478-7491 Short, J.J., Pereboev, A.V., Kawakami, Y., Vasu, C., Holterman, M.J. & Curiel, D.T. (2004) Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology. 322, 349-359 Short, J.J., Vasu, C., Holterman, M.J., Curiel, D.T. & Pereboev, A. (2006) Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors.","cites":null},{"id":37505667,"title":"Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene.","authors":[],"date":"2001","doi":null,"raw":"Tuboly, T. & Nagy, E. (2001) Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene. J. Gen. Virol. 82, 183\u2013190.","cites":null},{"id":37505646,"title":"Construction of non-defective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome.","authors":[],"date":"1985","doi":null,"raw":"Saito, I., Oya, Y., Yamamoto, K., Yuasa, T. & Shimojo, H. (1985) Construction of non-defective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54, 711-719 Sakurai, F., Akitomo, K., Kawabata, K., Hayakawa, T. & Mizuguchi, H. (2007) Downregulation of human CD46 by adenovirus serotype 35 vectors. Gene Ther. 14, 912-919 Sakurai, F., Nakamura, S.I., Akitomo, K., Shibata, H., Terao, K., Kawabata, K., Hayakawa, T. & Mizuguchi, H. (2008) Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates. Mol. Ther. 16, 726-733 Sakurai, F., Nakamura, S.I., Akitomo, K., Shibata, H., Terao, K., Kawabata, K., Hayakawa, T. & Mizuguchi, H. (2009) Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates. Gene Ther. 16, 297-302 Sakurai, F., Nakashima, K., Yamaguchi, T., Ichinose, T., Kawabata, K., Hayakawa, T. & Mizuguchi, H. (2010) Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35. J. Control. Release Aug 26. [Epub ahead of print] Salone, B., Martina, Y., Piersanti, S., Cundari, E., Cherubini, G., Franqueville, L., Failla, C.M., Boulanger, P. & Saggio, I. (2003) Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J. Virol. 77, 13448-13454 Sallusto, F. and Lanzavecchia, A. (1995) Dendritic cells use macropinocytosis and the mannose recptor to concentrate antigen to the MHC class II compartment.","cites":null},{"id":37505731,"title":"Contrasting effects of TGF-\u03b2 and TNF-\u03b1 on the development of dendritic cells from progenitors in mouse bone marrow.","authors":[],"date":"1997","doi":null,"raw":"Gene Ther. 18, 753-762 Yamaguchi, Y., Tsumura, H., Mitsuru, M. & Inaba, K., 1997. Contrasting effects of TGF-\u03b2 and TNF-\u03b1 on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15, 144-151 Yang, H., Guimar\u00e3es-Walker, A., Hibbs, S., Dong, T., Stacey, A., Borrow, P., Hanke, T., Davenport, M.P., McMichael, A. & Dorrell, L. (2009) Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption. AIDS 23, 2226-2230 Yang, Z.Y., Wyatt, L.S., Kong, W.P., Moodie, Z., Moss, B. & Nabel, G.J. (2003). Overcoming immunity to a viral vaccine by DNA priming before vector boosting. J. Virol. 77, 799-786.","cites":null},{"id":37505475,"title":"Crystal structure of species D adenovirus fibre knobs and their sialic acid binding sites.","authors":[],"date":"2004","doi":null,"raw":"Burmeister, W.P., Guilligay, D., Cusack, S., Wadell, G. & Arnberg, N. (2004) Crystal structure of species D adenovirus fibre knobs and their sialic acid binding sites. J. Virol. 78, 7727\u20137736 Caravokyri, C. & Leppard, K.N. (1995). Constitutive episomal expression of polypeptide-IX (pIX) in a 293- based cell-line complements the deficiency of pIX mutant adenovirus type-5. J. Virol. 69, 6627-6633 Carlin, C., Tollefson, A.E., Brady, H.A., Hoffman, B.L., & Wold, W.S.M. (1989). Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell 57, 135-144.","cites":null},{"id":37505726,"title":"Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution.","authors":[],"date":"1994","doi":null,"raw":"Xia, D., Henry, L.J., Gerard, R.D. & Deisenhofer, J. (1994) Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure 15, 1259-1270 Xiang, Z., Gao, G., Reyes-Sandoval, A., Cohen, C.J., Li, Y., Bergelson, J.M., Wilson, J.M. & Ertl, H.C. (2002) Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J. Virol. 76, 2667-2675 Xiang, Z.Q., Knowles, B.B., McCarrick, J.W., & Ertl, H.C. (1995). Immune effector mechanisms required for protection to rabies virus. Virology 214, 398\u2013404.","cites":null},{"id":37505431,"title":"Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression.","authors":[],"date":"1999","doi":null,"raw":"Bennett, E.M., Bennink, J.R., Yewdell, J.W. & Brodsky, F.M. (1999). Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162, 5049-5052 Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L. & Finberg R.W. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. J. Immunol. 156, 4415-4421 Bergelson, J.M., Krithivas, A., Celi, L., Droguett, G., Horwitz, M.S., Wickham, T., Crowell, R.L. & Finberg, R.W. (1998) The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 72, 415-419 Berk, A. (2007) Adenoviridae and their replication. In Fields Virology, 5 th edn.","cites":null},{"id":37505509,"title":"Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells.","authors":[],"date":"2009","doi":null,"raw":"J. Virol. 74, 10508-10513 Hall, K., Blair Zadjel, M.E. & Blair, G.E. (2009) Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells. Virology 392, 222-229 Hanke, T., Barnfield, C., Wee, E. G.-T., \u01fagren, L., Samuel, R.V., Larke, N. & Liljestr\u00f6m, P. (2003). Construction and immunogenicity in a prime\u2013boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine. J. Gen. Virol. 84, 361\u2013368.","cites":null},{"id":37505428,"title":"Dendritic cells as therapeutic vaccines against","authors":[],"date":"2005","doi":null,"raw":"Acad. Sci. 1174, 24-32 Banchereau, J. & Palucka, A.K. (2005) Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol.5, 296-306 Banchereau, J., Schuler-Thurner, B., Palucka, A.K. & Schuler, G. (2001) Dendritic cells as vectors for therapy. Cell 106, 271-274 Banchereau, J. and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252 Barnstable, C.J., Bodmer, W.F., Brown, G., Galfre, G., Milstein, C., Williams, A.F. & Ziegler, A. (1978). Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens \u2013 New tools for genetic analysis.  Cell 14, 19-20 Barouch, D.H. (2008) Challenges in the development of an HIV-1 vaccine. Nature 455, 613-619 Barouch, D.H., McKay, P.F., Sumida, S.M., Santra, S., Jackson, S.S., Gorgone, D.A., Lifton, M.A., Chakrabarti, B.K., Xu, L., Nabel, G.J. & Letvin, N.L. (2003). Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting HIV-1 vaccines. J. Virol. 77, 8729-8736 Barouch, D.H., Pau, M.G., Custers, J.H., Koudstaal, W., Kostense, S., Havenga, M.J., Truitt, D.M., Sumida, S.M., Kishko, M.G., Arthur, J.C., Korioth-Schmitz, B., Newberg, M.H., Gorgone, D.A., Lifton, M.A., Panicali, D.L., Nabel, G.J., Letvin, N.L. & Goudsmit, J. (2004) Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J. Immunol. 172, 6290-6297 Barr\u00e9-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. & Montagnier, L. (1983) Isolation of a T-lymphotrophic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871 Barr, J.N. (1993) Expression of the nucleoprotein and phosphoprotein genes of pneumonia virus of mice and specific interactions of the gene products. PhD thesis, Faculty of Biological Sciences, University of Warwick.","cites":null},{"id":37505625,"title":"Dendritic cells: a critical player in cancer therapy.","authors":[],"date":"2008","doi":null,"raw":"In Fields Virology, 5 th edn. Philadelphia, Pa. Lippincott, Williams & Wilkins Palucka, A.K., Ueno, H., Fay, J. & Banchereau, J. (2008) Dendritic cells: a critical player in cancer therapy. J. Immunother. 31, 798-805 Pantaleo, G., Demarest, J.F., Schacker, T., Vaccarezza, M., Cohen, O.J., Daucher, M., Graziosi, C., Schnittman, S.S., Quinn, T.C., Shaw, G.M., Perrin, L., Tambussi, G., Lazzarin, A., Sekaly, R.P., Soudeyns, H., Corey, L. & Fauci, A.S. (1997). The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. PNAS 94, 254\u2013258 Papagatsias, T., Rozis, G., Athanasopoulos, T., Gotch, F., Dickson, G. & Patterson, S. (2008) Activity of different vaccine-associated promoter elements in human dendritic cells. Immunol. Lett. 115, 117-125 Parker, A.L., McVey, J.H., Doctor, J.H., Lopez-Franco, O., Waddington, S.N., Havenga, M.J., Nicklin, S.A. & Baker, A.H. (2007) Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J. Virol. 81, 3627-3631 Parker, A.L., Waddington, S.N., Nicol, C.G., Shayakhmetov, D.M., Buckley, S.M., Denby, L., Kemball-Cook, G., Ni, S., Lieber, A., McVey, J.H., Nicklin, S.A. & Baker, A.H. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 15, 2554-2561 Pasarica, M., Loiler, S. & Durhandhar, N.V. (2008) Acute effect of infection by adipogenic human adenovirus Ad36. Arch. Virol. 153, 2097-2102 Perreau, M. & Kremer, E.J. (2006) The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy. Mol. Biotechnol. 34, 247\u2013256 Persson, B.D., M\u00fcller, S., Reiter, D.M., Schmitt, B.B., Marttila, M., Sumowski, C.V., Schweizer, S., Scheu, U., Ochsenfeld, C., Arnberg, N. & Stehle, T. (2008) An arginine switch in the species B adenovirus knob determines high-affinity engagement of cellular receptor CD46. J. Virol. 83, 673-686 Persson, B.D., Reiter, D.M., Marttila, M., Mei, Y.F., Casasnovas, J.M., Arnberg, N.","cites":null},{"id":37505511,"title":"Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in","authors":[],"date":"2000","doi":null,"raw":"J. Gen. Virol.79, 83-90 Hanke, T. & McMichael, A.J. (2000) Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Nat. Med. 6, 951-955 Hanke, T., Goonetilleke, N., McMichael, A.J. & Dorrell, L. (2007) Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectores human immunodeficiency type 1 clade A vaccine focusing on T cell induction. J. Gen. Virol. 88, 1-12 Hanke, T., McMichael, A.J., Samuel, R.V., Powell, L.A., McLoughlin, L., Crome, S.J. & Edlin, A. (2002) Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya. Vaccine 21, 108-114 Harrison, T., Graham, E.L. & Williams, J. (1977) Host-range mutants of adenovirus type 5 defective for growth in HeLa cells. Virology 77, 319-329 Hartman, Z.C., Appledorn, D.M. & Amalfitano, A. (2008) Adenovirus vector induced innate immune responses: Impace upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 132, 1-14 Hartman, Z.C., Black, E.P. & Amalfitano, A. (2007). Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 358, 357\u2013372 He, Z., Wlazlo, A.P., Kowalczyk, D.W., Cheng, J., Xiang, Z.Q., Giles-Davis, W. & Ertl, H.C. (2000) Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology 25, 146-161 Heath, W.R., Belz, G.T., Behrens, G.M., Smith, C.M., Forehan, S.P., Parish, I.A., Davey, G.M., Wilson, N.S., Carborne, F.R. and Villadangos, J.A. (2004) Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9\u201326 Heemskerk, B., Lankester, A.C., van Vreeswijk, T., Beersma, M.F., Claas, E.C., Veltrop-Duits, L.A., Kroes, A.C., Vossen, J.M., Schilham, M.W. & van Tol, M.J. (2005) Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J. Infect. Dis.15, 520-530 Heemskerk, B., Veltrop-Duits, L.A., van Vreeswijk, T., ten Dam, M.M., Heidt, S., Toes, R.E., van Tol, M.J. & Schilham, M.W. (2003) Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J. Virol. 77, 6562-6566 Hierholzer, J.C., Guyer, B., O'Day, D. & Schaffner, W. (1974) Letter: Adenovirus type 19 keratoconjunctivitis. N. Engl. J. Med. 290, 1436 Hilgendorf, A., LindBerk, J., Ruzsics, Z., Honing, S., Elsing, A., Lofqvist, M., Engelmann, H., & Burgert, H.-G. (2003). Two distinct transport motifs in the adenovirus E3\/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. The Journal of Biological Chemistry 278, 51872-51884.","cites":null},{"id":37505656,"title":"Development of a preventive vaccine for Ebola virus infection in primates.","authors":[],"date":"2000","doi":null,"raw":"Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.-Y. & Nabel, G.J. (2000) Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605-609 Sumida, S.M., Truitt, D.M., Lemckert, A.A., Vogels, R., Custers, J.H., Addo, M.M., Lockman, S., Peter, T., Peyerl, F.W., Kishko, M.G., Jackson, S.S., Gorgone, D.A., Lifton, M.A., Essex, M., Walker, B.D., Goudsmit, J., Havenga, M.J. & Barouch, D.H. (2005) Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein, J Immunol 174, 7179\u20137185 Swenson, P.D., Lowens, M.S., Celum, C.L. & Hierholzer, J.C. (1995) Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J. Clin. Microbiol. 33, 2728-2731 Takahashi, M.N., Rolling, J.A. & Owen, K.E. (2010) Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates. J. Virol. 7, 39 Takahashi, H., Cohen, J., Hosmalin, A., Cease, K.B., Houghten, R., Cornette, J.L., DeLisi, C., Moss, B., Germain, R.N. & Berzofsky, J.A. (1988) An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility molecule- restricted murine cytotoxic T lymphocytes. PNAS 85, 3105\u20133109.","cites":null},{"id":37505647,"title":"Downregulation by cytokines and bacterial products.","authors":[],"date":"1989","doi":null,"raw":"Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.","cites":null},{"id":37505665,"title":"Downregulation of natural killer cellactivating ligand CD155 by human cytomegalovirus UL141.","authors":[],"date":"2005","doi":null,"raw":"Tomasec, P., Wang, E.C., Davison, A.J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B.P., Morris, R.J., Llewellyn-Lacey, S., Rickards, C., Nomoto, A., Sinzger, C. & Wilkinson, G.W. (2005). Downregulation of natural killer cellactivating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6, 181-188 Tomko, R.P., Xu, R. & Philipson, L. (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. PNAS 94, 3352\u20133356.","cites":null},{"id":37505692,"title":"E3 transcription unit of adenovirus.","authors":[],"date":"1995","doi":null,"raw":"Edited by Knipe, D.M. and Howley, P.M. Philadelphia, Pa.  Lippincott, Williams and Wilkins Wold, W., Tollefson, A., & Hermiston, T. (1995). E3 transcription unit of adenovirus. Curr. Top. Microbiol. Immunol. 199, 237-274.","cites":null},{"id":37505440,"title":"E3\/19K&quot; protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell surface-expression of histocompatibility class I antigens.","authors":[],"date":"1987","doi":null,"raw":"Burgert, H.-G., Maryanski, J.L. & Kvist, S. (1987). &quot;E3\/19K&quot; protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell surface-expression of histocompatibility class I antigens. PNAS 84, 1356-1360.","cites":null},{"id":37505435,"title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study). A double-blind, randomised, placebo-controlled, test-of-concept trial.","authors":[],"date":null,"doi":null,"raw":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study). A double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet  372, 1881\u20131893.","cites":null},{"id":37505489,"title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.","authors":[],"date":"1996","doi":null,"raw":"Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A. & Mehtali, M. (1996). Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70, 4805\u20134810.","cites":null},{"id":37505653,"title":"Engineered expression of the coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirusmediated gene transfer.","authors":[],"date":"2002","doi":null,"raw":"Stockwin, L.H., Matzow, T., Georgopoulos, N.T., Stanbridge, L.J., Jones, S.V., Martin, I.G., Blair-Zajdel, M.E. & Blair, G.E. (2002). Engineered expression of the coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirusmediated gene transfer. J. Immunol. Methods 259, 205\u2013215.","cites":null},{"id":37505614,"title":"Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.","authors":[],"date":"2005","doi":null,"raw":"Clin. Microbiol. 29, 1286-1289 Nordstr\u00f6m, E.K.L., Forsell, M.N.E., Barnfield, C., Bonin, E., Hanke, T., Sundstr\u00f6m, M., Karlsson, G.B. & Liljestr\u00f6m, P. (2005). Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1. J.","cites":null},{"id":37505518,"title":"Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism.","authors":[],"date":"1992","doi":null,"raw":"Hoffman, P., Rajakumar, P., Hoffman, B.L., Heuertz, R., Wold, W.S.M., & Carlin, C. (1992). Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism. J. Virol. 66, 197-203.","cites":null},{"id":37505483,"title":"Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet.","authors":[],"date":"2004","doi":null,"raw":"Cattaneo, R. (2004) Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78, 4385-4388 Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., Lanzavecchia, A. & Banchereau, J. (1997) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood. 90, 1458\u20131470 Cebere, I., Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J.E., Darwin, S.C., Fast, P.E., Conlon, C., RowlandJones, S., McMichael, A.J. & Hanke, T. (2006) Phase I clinical trial safety of DNAand modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. Vaccine 24, 417-425 Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A.","cites":null},{"id":37505575,"title":"Further characterization of 41 isolates of adenovirus types 19\/37 by serum neutralization and DNA restriction enzyme analysis.","authors":[],"date":"1986","doi":null,"raw":"Meng, Z.D., Kennett, M.L., Rodger, S.M., Dickson, K.E., Anderson, B.N. & Gust, I.D. (1986) Further characterization of 41 isolates of adenovirus types 19\/37 by serum neutralization and DNA restriction enzyme analysis. J. Hyg. 97, 377-383 Mercier, S., Gah\u00e9ry-Segard, H., Monteil, M., Lengagne, R., Guillet, J.G., Eloit, M. & Denesvre C. (2002) Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product. J. Virol. 76, 2899-2911 Mitani, K., Graham, F.L., Caskey, C.T. & Kochanek, S. (1995). Rescue, Propagation, and Partial-Purification Of a Helper Virus- Dependent Adenovirus Vector. PNAS 92, 3854-3858 Mittereder, N., March, K.L. & Trapnell, B.C. (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509 Moore, J.P. & Ho, D.D. (1993) Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67, 863-875 Morelli, A.E., Larregina, A.T., Ganster, R.W., Zahorchak, A.F., Plowey, J.M., Takayama, T., Logar, A.J., Robbins, P.D., Falo, L.D. & Thomson, A.W. (2000) Recombinant adenovirus induces maturation of dendritic cells via an NK\u03baBdependent pathway. J. Virol. 74, 9617-9624 Morral, N., O\u2019Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P.A., Zhou, H., Parks, R.J., Velji, R., Aguilar-Cordova, E., Wadsworth, S., Graham, F.L., Kochanek, S., Carey, K.D. & Beaudet, A.L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. PNAS 96, 12816\u201312821 Morris, S.J. & Leppard, K.N. (2009) Adenovirus Serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. J. Virol. 83, 3049-3058 Muruve, D., Barnes, M., Stillman, I., & Libermann, T. (1999). Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophildependent hepatic injury in vivo. Hum. Gene Ther. 10, 965\u2013976 Muruve, D.A., P\u00e9trilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., Parks, R.J. & Tschopp, J. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107 Mwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E.G., Beattie, T., Chen, Y.H., Dorrell, L., McShane, H., Schmidt, C., Brooks, M., Patel, S., Roberts, J., Conlon, C., Rowland-Jones, S.L., Bwayo, J.J., McMichael, A.J. & Hanke, T. (2004).","cites":null},{"id":37505436,"title":"Gangliosides influence experimental influenza virus infection in mice.","authors":[],"date":"1989","doi":null,"raw":"Bukrinskaya, A.G., Petrova, I.G., Podchernyaeva, R.Y., Prokazova, N.V., Zvezdina, N.D. & Bergelson, L.D. (1989) Gangliosides influence experimental influenza virus infection in mice. J. Gen. Virol. 70, 2433-2437.","cites":null},{"id":37505571,"title":"Gene-modified dendritic cells for immunotherapy against cancer.","authors":[],"date":"2002","doi":null,"raw":"Lunqvist A & Pisa, P. (2002) Gene-modified dendritic cells for immunotherapy against cancer. Med. Oncol. 19, 197-211 Lutz, M.B., Kukutsch, N., Ogilvie, A.L., R\u00f6ssner, S., Koch, F., Romani, N. & Schuler, G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92 Lusky, M., Christ, M., Rittner, K., Dieterle, A., Dreyer, D., Mourot, B., Schultz, H., Stoeckel, F.,Pavirani, A. & Mehtali, M. (1998). In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1\/E2A, or E1\/E4 deleted. J. Virol. 72, 2022-2032 Lusky M., Grave, L., Dieterl\u00e9, A., Dreyer, D., Christ, M., Ziller, C., Furstenberger, P., Kintz, J., Hadji, D.A., Pavirani, A. & Mehtali, M. (1999) Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3. J. Virol. 73, 8308-8319 Madisch, I., W\u00f6lfel, R., Harste, G., Pommer, H., Heim, A. (2006). Molecular identification of adenovirus sequences: A rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J. Med. Virol. 78, 1210\u20131217 Maggon, K. & Barrik, S. (2004) New drugs and treatments for respiratory syncitial virus. Rev. Med. Virol. 14, 149-168 Marcos, M.A., Esperatti, M. & Torres, A. (2009) Viral pneumonia Curr. Opin.","cites":null},{"id":37505548,"title":"Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity","authors":[],"date":"2006","doi":null,"raw":"Lemckert, A.A.C., Grimbergen, J., Smits, S., Hartkoorn, E., Holterman, L., Berkhout, B., Barouch, D.H., Vogels, R., Quax, P., Goudsmit, J. & Havenga, M.J.E. (2006) Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity J. Gen. Virol 87, 2891-2899 Lemckert, A.A., Sumida, S.M., Holterman, L., Vogels, R., Truitt, D.M., Lynch, D.M., Nanda, A., Ewald, B.A., Gorgone, D.A., Lifton, M.A., Goudsmit, J., Havenga, M.J. & Barouch, D.H. (2005) Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity. J. Virol. 79, 9691-9704 Lemiale, F., Haddada, H., Nabel, G.J., Brough, D.E., King, C.R. & Gall, J.G. (2007).","cites":null},{"id":37505643,"title":"Generation of an adenoviral vaccine vector based on simian adenovirus 21.","authors":[],"date":"2006","doi":null,"raw":"Roy, S., Zhi, Y., Kobinger, G.P., Figueredo, J., Calcedo, R., Miller, J.R., Feldmann, H. & Wilson, J.M. (2006) Generation of an adenoviral vaccine vector based on simian adenovirus 21. J. Gen. Virol. 87, 2477-2485 Russell, W.C. (2000). Update on adenovirus and its vectors. J. Gen. Virol. 81, 2573-2604.","cites":null},{"id":37505427,"title":"Harnessing human dendritic cell subsets to design novel vaccines.","authors":[],"date":"2009","doi":null,"raw":"(2009) Harnessing human dendritic cell subsets to design novel vaccines. Ann. N. Y.","cites":null},{"id":37505648,"title":"Heterologous prime\/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors.","authors":[],"date":"2009","doi":null,"raw":"Santra, S., Sun, Y., Korioth-Schmitz, B., Fitzgerald, J., Charbonneau, C., Santos, G., Seaman, M.S., Ratcliffe, S.J., Montefiori, D.C., Nabel, G.J., Ertl, H.C. & Letvin, N.L. (2009) Heterologous prime\/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors. Vaccine 27, 5837-5845 Sas, S., Chan, T, Sami, A., El-Gayed, A. & Xiang, J. (2008) Vaccination of fibermodified adenovirus-transfected dendritic cells to express HER-2\/neu stimulates efficient HER-2\/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice. Cancer Gene Ther. 15, 655-666 Scaria, A. & Wold, W.S.M. (1994) Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of Adenovirus. Virology 205, 406-416 Schauer, R. (2009) Sialic acids as regulators of molecular and cellular interactions.","cites":null},{"id":37505760,"title":"Hexon gene switch strategy for the generation of chimeric recombinant adenovirus.","authors":[],"date":"2002","doi":null,"raw":"Youil, R., Toner, T.J., Su, Q., Chen, M., Tang, A., Bett, A.J. & Casimiro, D. (2002). Hexon gene switch strategy for the generation of chimeric recombinant adenovirus. Hum. Gene Ther. 13, 311\u2013320.","cites":null},{"id":37505573,"title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: A case-cohort analysis.","authors":[],"date":"2002","doi":null,"raw":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: A case-cohort analysis. Lancet 372, 1894\u20131905 McMichael, A., Mwau, M. & Hanke, T. (2002) Design and tests of an HIV vaccine.","cites":null},{"id":37505635,"title":"Human adenovirus type 19: genomic and bioinformatics analysis of a keratoconjunctivitis isolate. Virus Res.","authors":[],"date":"2009","doi":null,"raw":"Robinson, C.M., Shariati, F., Zaitshik, J., Gillaspy, A.F., Dyer, D.W. & Chodosh, J. (2009) Human adenovirus type 19: genomic and bioinformatics analysis of a keratoconjunctivitis isolate. Virus Res. 139, 122-126 Rodr\u00edguez, A., Mintardjo, R., Tax, D., Gillissen, G., Custers, J., Pau, M.G., Klap, J., Santra, S., Balachandran, H., Letvin, N.L., Goudsmit, J. & Radosevi\u0107, K. (2009) Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Vaccine 27, 6226-6233.","cites":null},{"id":37505487,"title":"Identification and characterization of membrane cofactor protein of human spermatozoa.","authors":[],"date":"1992","doi":null,"raw":"Cervoni, F., Oglesby, T.J., Adams, E.M., Milesifluet, C., Nickells, M., Fenichel, P., Atkinson, J.P., and Hsi, B.L. (1992). Identification and characterization of membrane cofactor protein of human spermatozoa. J. Immunol. 148, 1431\u20131437.","cites":null},{"id":37505556,"title":"Identification of a cell protein (FIP-3) as a modulator of NFkappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.","authors":[],"date":"1999","doi":null,"raw":"Nat. Rev. Immunol. 6, 930-939 Li, Y., Kang, J., Friedman, J., Tarassishin, L., Ye, J., Kovalenko, A., Wallach, D., & Horwitz, M. (1999). Identification of a cell protein (FIP-3) as a modulator of NFkappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. PNAS 96, 1042-1047.","cites":null},{"id":37505637,"title":"Identification of a conserved receptor-binding site on the fibre proteins of CARrecognizing adenoviridae.","authors":[],"date":"1994","doi":null,"raw":"Identification of a conserved receptor-binding site on the fibre proteins of CARrecognizing adenoviridae. Science 286, 1568-1571 Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. & Schuler, G. (1994) Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83\u201393 cRosario, M., Bridgeman, A., Quakkelaar, E.D., Quigley, M.F., Hill, B.J., Knudsen, M.L., Ammendola, V., Ljungberg, K., Borthwick, N., Im, E.J., McMichael, A.J., Drijfhout, J.W., Greenaway, H.Y., Venturi, V., Douek, D.C., Colloca, S., Liljestr\u00f6m, P., Nicosia, A., Price, D.A., Melief, C.J. & Hanke, T. (2010) Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. Eur. J. Immunol. 40, 1973-1984 aRosario, M., Fulkerson, J., Soneji, S., Parker, J., Im, E.J., Borthwick, N., Bridgeman, A., Bourne, C., Joseph, J., Sadoff, J.C. & Hanke, T. (2010). Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques. J. Virol. 84, 7815-7821 bRosario, M., Hopkins, R., Fulkerson, J., Borthwick, N., Quigley, M.F., Joseph, J., Douek, D.C., Greenaway, H.Y., Venturi, V., Gostick, E., Price, D.A., Both, G.W., Sadoff, J.C. & Hanke, T. (2010) Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques. J. Virol. 84, 5898-5908 Rosen, L., Hovis, J.F. & Bell, J.A. (1962). Further observation on typing adenoviruses and a description of two possible additional serotypes. Proc. Soc. Exp.","cites":null},{"id":37505616,"title":"Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.","authors":[],"date":"2003","doi":null,"raw":"Gen. Virol. 86, 349\u2013354 Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K. & Kato, N. (2003). Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J. Biol. Chem. 278, 10162\u201310173 O'Brien, K.L., Liu, J., King, S.L., Sun, Y.H., Schmitz, J.E., Lifton, M.A., Hutnick, N.A., Betts, M.R., Dubey, S.A., Goudsmit, J., Shiver, J.W., Robertson, M.N., Casimiro, D.R. & Barouch, D.H. (2009) Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nat. Med. 15, 873-875 O'Connor, D., Friedrich, T., Hughes, A., Allen, T.M. & Watkins, D. (2001) Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection. Immuno. Rev. 183, 115-126 Ogra, P.L. (2004) Respiratory syncytial virus: the virus, the disease and the immune response, Paediatr. Respir. Rev. 5, 119\u2013126 Ondondo, B.O., Yang, H., Dong, T., di Gleria, K., Suttill, A., Conlon, C., Brown, D., Williams, P., Rowland-Jones, S.L., Hanke, T., McMichael, A.J. & Dorrell, L. (2006) Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.","cites":null},{"id":37505510,"title":"Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankarabased multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.","authors":[],"date":"1998","doi":null,"raw":"Hanke, T., Blanchard, T.J., Schneider, J., Ogg, G.S., Tan, R., Becker, M., Gilbert, S.C., Hill, A.V., Smith, G.L. & McMichael, A. (1998) Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankarabased multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.","cites":null},{"id":37505438,"title":"Immunomodulatory Functions Encoded by the E3 Transcription Unit of Adenoviruses.","authors":[],"date":"2000","doi":null,"raw":"Burgert, H-G., Blusch, J.H. (2000). Immunomodulatory Functions Encoded by the E3 Transcription Unit of Adenoviruses. Virus Genes 21, 13-25.","cites":null},{"id":37505545,"title":"Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and D fibres.","authors":[],"date":"2006","doi":null,"raw":"Mol. Ther. 17, 1333-1339 Lecollinet, S., Gavard, F., Havenga, M.J., Spiller, O.B., Lemckert, A., Goudsmit, J., Eloit, M., Richardson, J. (2006) Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and D fibres. J. Virol. 80, 2747\u20132759.","cites":null},{"id":37505501,"title":"In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors.","authors":[],"date":"1973","doi":null,"raw":"Immuno. Rev. 214, 130-142 Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, P., Kersey, J.H., Dosik, H. & Pars, W.P. (1973) In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417\u20131423 Ginsberg, H.S., Moldawer, L.L., Sehgal, P.B., Redington, M., Kilian, P.L., Chanock, R.M. & Prince, G.A. (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. PNAS 88, 1651-1655 Ghosh-Choudhury, G., Haj-Ahmad, Y. & Graham, F.L. (1987) Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J. 6, 1733-1739 Ginhoux, F., Collin, M.P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., Ochando, J., Kissenpfennig, A., Malissen, B., Grisotto, M., Snoeck, H., Randolph, G.","cites":null},{"id":37505650,"title":"Inhibition of TNF receptor 1 internalisation by adenovirus 14.7K as a novel immnune escape mechanism.","authors":[],"date":"2006","doi":null,"raw":"& Scutze, S. (2006). Inhibition of TNF receptor 1 internalisation by adenovirus 14.7K as a novel immnune escape mechanism. J. Clin. Invest. 116, 2901-2913 Schneider, J., Gilbert, S.C., Blanchard, T.J., Hanke, T., Robson, K.J., Hannan, C.M., Becker, M., Sinden, R., Smith, G.L. & Hill, A.V. (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4, 397-402 Schnell, M.A., Zhang, Y., Tazelaar, J., Gao, G.P., Yu, Q.C., Qian, R., Chen, S.J., Varnavski, A.N., LeClair, C., Raper, S.E. & Wilson, J.M. (2001) Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther. 3, 708-722 Schuler, G., Schuler-Thurner, B. & Steinman, R.M. (2003) The use of dendritic cells in cancer immunotherapy. Curr. Op. Immun. 15, 138-147 Segerman, A., Atkinson, J.P., Marttila, M., Dennerquist, V., Wadell, G. & Arnberg, N. (2003) Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77, 9183\u2013 Seiradake, E., Henaff, D., Wodrich, H., Billet, O., Perreau, M., Hippert, C., Mennechet, F., Schoehn, G., Lortat-Jacob, H., Dreja, H., Ibanes, S., Kalatzis, V., Wang, J.P., Finberg, R.W., Cusack, S. & Kremer, E.J. (2009) The cell adhesion molecule &quot;CAR&quot; and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog.5, 1-15 Seiradake, E., Lortat-Jacob, H., Billet, O., Kremer, E.J. & Cusack, S. (2006) Structural and mutational analysis of human Ad37 and canine adenovirus 2 fibre heads in complex with the D1 domain of coxsackie and adenovirus receptor. J. Biol. Chem. 281, 33704\u201333716 Seshidhar Reddy, P., Ganesh, S., Limbach, M.P., Brann, T., Pinkstaff, A., Kaloss, M., Kaleko, M. & Connelly, S. (2003) Development of adenovirus serotype 35 as a gene transfer vector. Virology 311, 384-393 Sester, M. & Burgert, H-G. (1994). Conserved Cysteine Residues withing the E3\/19K Protein of Adenovirus Type 2 Are Essential for Binding to Major Histocompatibility Complex Antigens. J. Virol. 68, 5423-5432.","cites":null},{"id":37505694,"title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.","authors":[],"date":"1997","doi":null,"raw":"Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37\u201344 Wu, E., Pache, L., Von Seggern, D.J., Mullen, T.M., Mikyas, Y., Stewart, P.L. & Nemerow, G.R. (2003) Flexibility of the adenovirus fiber is required for efficient receptor interaction. J. Virol. 77, 7225-7235 Wu, E., Fernandez, J., Fleck, S.K., Von Seggern, D.J., Huang, S. & Nemerow, G.R. (2001) A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. Virology 279: 78\u201389.","cites":null},{"id":37505560,"title":"Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers.","authors":[],"date":"1997","doi":null,"raw":"Li, Y., Kang, J., & Horwitz, M. (1997). Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers. J. Virol. 71, 1576-1582.","cites":null},{"id":37505562,"title":"Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.","authors":[],"date":"1998","doi":null,"raw":"Li, Y., Kang, J., & Horwitz, M. (1998). Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol. 18, 1601-1610.","cites":null},{"id":37505496,"title":"Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated Dendritic cells.","authors":[],"date":"2006","doi":null,"raw":"De Gruijl, T.D., Ophorst, O.J.A.E., Goudsmit, J., Verhaagh, S., Lougheed, S.M., Radosevic, K., Havenga, M.J.E. & Scheper, R.J. (2006) Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated Dendritic cells. J. Immunol. 177, 2208-2215 Dechecchi, M.C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M. & Cabrini, G. (2001). Heparan sulphate glycosaminoglycans are receptors sufficient to mediate initial binding of adenovirus types 2 and 5. J. Virol. 75, 8772-8780 Defer, C., Belin, M.T., Caillet-Boudin, M.L. & Boulanger, P. (1990) Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J. Virol. 64, 3661-3673 Delorme, C., Brussow, H., Sidoti, J., Roche, N., Karlsson, K.A., Neeser, J.R. & Teneberg, S. (2001) Glycosphingolipid binding specificities of rotavirus: Identification of a sialic acid-binding epitope. J. Virol. 75, 2276-2287 Denby, L., Work, L.M., Graham, D., Hsu, C., von Seggern, D.J., Nicklin, S.A. & Baker, A.H. (2004) Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo. Hum. Gene Ther. 15, 1054-1064 Derdeyn, C.A. & Silvestri, G. (2005) Viral and host factors in the pathogenesis of HIV infection. Curr. Op. Immun. 17, 366-373 Deryckere, F. & Burgert, H-G. (1996). Early Region 3 of Adenovirus Type 19 (Subgroup D) Encodes an HLA-Binding Protein Distinct from That of Subgroups B and C. J. Virol. 70, 2832-2841 Desmyter, J., De Jong, J.C., Slaterus, K.W. & Verlaeckt, H. (1974) Letter: Keratoconjunctivitis caused by Adenovirus Type 19. Br. Med. J. 4, 406 Deutscher, S.L., Nuwavhid, N., Stanley, P., Briles, E.I. & Hirschberg, C.B. (1984) Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell 6, 121-128 De Vries, I.J., Lesterhuis, W.J., Scharenborg, N.M., Engelen, L.P., Ruiter, D.J., Gerritsen, M.J., Croockewit, S., Britten, C.M., Torensma, R., Adema, G.J., Figdor, C.G. & Punt, C.J. (2003) Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin. Cancer Res. 9, 5091-5100 Dhiman, N., Jacobsen, R.M. & Poland, G.A. (2004) Measles virus receptors: SLAM and CD46. Rev. Med. Virol. 14, 217-229 Di Guilmi, A.M., Barge, A., Kitts, P., Gout, E. & Chroboczek, J. (1995) Human adenovirus serotype 3 (Ad3) and the Ad3 fiber protein bind to a 130-kDa membrane protein on HeLa cells. Virus Res. 38, 71-81 Ding, E.Y., Hodges, B.L., Hu, H., McVie-Wylie, A.J., Serra, D., Migone, F.K., Pressley, D., Chen, Y.T. & Amalfitano, A. (2001). Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice. Hum. Gene Ther. 12, 955-65 Dobner, T., Horikoshi, N., Rubenwolf, S. & Shenk, T. (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272, 1470-1473 Domachowske, J.B., Bonville, C.A., Ali-Ahmad, D., Dyer, K.D., Easton, A.J. & Rosenberg, H.F. (2001). Glucocorticoid administration accelerates mortality of Pneumovirus-infected mice. J. Infect Dis. 184, 1518-1523 Domachowske, J.B., Bonville, C.A., Dyer, K.D., Easton, A.J. & Rosenberg, H.F. (2000). Pulmonary eosinophilia and production of MIP-1  are prominent responses to infection with pneumonia virus of mice. Cell Immunol. 200, 98-104 Domachowske, J.B., Bonville, C.A., Easton, A.J. & Rosenberg, H.F. (2002). Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections. J. Infect. Dis. 186, 8-14 Dorrell, L., Williams, P., Suttill, A., Brown, D., Roberts, J., Conlon, C., Hanke, T. & McMichael, A. (2007) Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag\/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy. Vaccine  25, 3277-3283 Dorrell, L., Yang, H., Iversen, A.K., Conlon, C., Suttill, A., Lancaster, M., Dong, T., Cebere, I., Edwards, A., Rowland-Jones, S., Hanke, T., McMichael, A.J. (2005) Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag\/poly-epitope DNA vaccine. AIDS 19, 1321-1323 Dorrell, L., Yang, H., Ondondo, B., Dong, T., di Gleria, K., Suttill, A., Conlon, C., Brown, D., Williams, P., Bowness, P., Goonetilleke, N., Rostron, T., Rowland-Jones, S., Hanke, T. & McMichael, A. (2006) Expansion and diversification of virusspecific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara\/HIV-1 Gag vaccine. J. Virol. 80, 4705-4716 Dudziak, D., Kamphorst, A.O., Heidkamp, G.F., Buchholz, V., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.W., Park, C.G., Steinman, R.M. & Nussenzweig, M.C. (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107\u2013111 Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamastakis, K., Lin, JH., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G. & Tsichlis, P.N. (2000) TNF-\u03b1 induction by LPS is regulated post-transcriptionally via a Tpl2\/ERKdependent pathway. Cell 7, 1071-1083 Elices, M.J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S., Hemler, M.E. & Lobb, R.R. (1990) VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4\/fibronectin binding site. Cell 23, 577-584 Elsing, A. & Burgert, H-G. (1998). The adenovirus E3\/10.4K-14.5K proteins downmodulate the apoptosis receptor Fas\/Apo-1 by inducing its internalisation. PNAS 95, 10072-10077 Emini, E.A., Schleif, W.A., Nunberg, J.H., Conley, A.J., Eda, Y., Tokiyoshi, S., Putney, S.D., Matsushita, S., Cobb, K.E., Jett, C.M., Eichberg, J.W. & Murthy, K.K. (1992) Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 20, 728-730 Enders, J.F., Bell, J.A., Dingle, J.H., Francis, T. Hilleman, M.R., Huebner, R.J. & Payne, A.M. (1956) Adenoviruses: group name proposed for new respiratory-tract viruses. Science 124, 119-120 Endter, C. & Dobner, T. (2004) Cell transformation by human adenoviruses. Curr Top. Microbiol. Immunol. 273, 163-174 Engelmann, I., Madisch, I., Pommer, H. & Heim, A. (2006) An outbreak of epidemic keratoconjunctivitis caused by a new intermediate adenovirus 22\/H8 identified by molecular typing. Clin. Infect. Dis. 43, 64-66 Estcourt, M.J., McMichael, A.J. & Hanke, T. (2005). Altered primary CD8+ T cell response to a modified virus Ankara (MVA)- vectored vaccine in the absence of CD4+ T cell help. Eur. J. Immunol. 35, 3460\u20133467 Excoffon, K.J., Gansemer, N.D., Mobily, M.E., Karp, P.H., Parekh, K.R. & Zabner, J. (2010) Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia. PLoS One 26, e9909.","cites":null},{"id":37505566,"title":"Isoforms differ in protection against the classical pathway of complement.","authors":[],"date":"1991","doi":null,"raw":"Isoforms differ in protection against the classical pathway of complement. Cell 39, 295-299 Liszewski, M.K., Post, T.W. & Atkinson, J.P. (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9, 431-455 Liu, Q. & Muruve, D.A. (2003) Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10, 935-940 Liu, Y-J. (2003) Dendritic Cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-62 Lonberg-Holm, K., Crowell, R.L., Philipson, L. (1976) Unrelated animal viruses share receptors. Nature 259, 679\u2013681.","cites":null},{"id":37505538,"title":"Isolation of deletion and substitution mutants of adenovirus type 5.","authors":[],"date":"1978","doi":null,"raw":"Jones, N.C. & Shenk, T. (1978). Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13, 181-186.","cites":null},{"id":37505670,"title":"Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition.","authors":[],"date":"2007","doi":null,"raw":"van der Aar, A.M., Sylva-Steenland, R.M., Bos, J.D., Kapsenberg, M.L., de Jong, E.C. & Teunissen, M.B. (2007) Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 178, 1986\u20131990 van de Ven, R., Lindenberg, J.J., Oosterhoff, D., van den Tol, M.P., Rosalia, R.A., Murakami, M., Everts, M., Scheffer, G.L., Scheper, R.J., de Gruijl, T.D. & Curiel, D.T. (2009) Selective transduction of mature DC in human skin and lymph nodes by CD80\/CD86-targeted fiber-modified adenovirus-5\/3. J. Immunother. 32, 895-906 Verhaagh, S., de Jong, E., Goudsmit, J., Lecollinet, S., Gillissen, G., de Vries, M., van Leuven, K., Que, I., Ouwehand, K., Mintardjo, R., Weverling, G.J., Radosevic, K., Richardson, J., Eloit, M., Lowik, C., Quax, P. & Havenga, M. (2006) Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J. Gen. Virol. 87, 255-265 Virtanen, A., Gilardi, P., Naslund, A., LeMoullec, J. M., Pettersson, U. & Perricaudet, M. (1984). mRNAs from human adenovirus 2 early region 4. J. Virol. 51, 822-831 Vogels, R., Zuijdgeest, D., Rijnsoever, R van., Hartkoorn, E., Damen, I., de Bethune, M-P., Kostense, S., Penders, G., Helmus, H., Koudstaal, W., Cecchini, M., Wetterwald, A., Sprangers, M., Lemckert, A., Ophorst, O., Koel, B., vanMeerendonk, M., Quax, P., Panitti, L., Grimbergen, J., Bout, A., Goudsmit, J & Havenga, M. (2003). Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77, 8263\u20138271 Vos, A., Neubert, A., Pommerening, E., M\u00fcller, T., D\u00f6hner, L., Neubert, L. & Hughes, K. (2001). Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J. Gen. Virol. 82, 2191-2197 Waddington, S.N., McVey, J.H., Bhella, D., Parker, A.L., Barker, K., Atoda, H., Pink, R., Buckley, S.M., Greig, J.A., Denby, L., Custers, J., Morita, T., Francischetti, I.M., Monteiro, R.Q., Barouch, D.H., van Rooijen, N., Napoli, C., Havenga, M.J., Nicklin, S.A. & Baker, A.H. (2008). Adenovirus serotype 5 hexon mediates liver gene transfer. Cell. 132, 397-409 Waddington, S.N., Parker, A.L., Havenga, M., Nicklin, S.A., Buckley, S.M., McVey, J.H. & Baker, A.H. (2007) Targeting of adenovirus serotype 5 (Ad5) and 5\/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J. Virol. 81, 9568-9571 Wadell, G. (1999). Adenoviruses (Adenoviridae): General features of adenoviruses.","cites":null},{"id":37505724,"title":"Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis.","authors":[],"date":"2004","doi":null,"raw":"Wu, E., Trauger, S.A., Pache, L., Mullen, T.M., von Seggern, D.J., Siuzdak, G. & Nemerow, G.R. (2004). Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J. Virol. 78, 3897\u20133905.","cites":null},{"id":37505429,"title":"Modifying adenoviral vectors for use as gene-based cancer vaccines.","authors":[],"date":"2004","doi":null,"raw":"Basak, S.K., Kiertscher, S.M., Harui, A. & Roth, M.D. (2004) Modifying adenoviral vectors for use as gene-based cancer vaccines. Viral. Immunol 17, 182-196 Basner-Tschakarjan, E., Gaffal, E., O'Keeffe, M., Tormo, D., Limmer, A., Wagner, H., Hochrein, H. & T\u00fcting, T. (2006) Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J.","cites":null},{"id":37505533,"title":"Multivalent sialic acid conjugates inhibit adenovirus type 37 from binding to and infecting human corneal epithelial cells.","authors":[],"date":"2007","doi":null,"raw":"Johansson, S.M., Nilsson, E.C., Elofsson, M., Ahlskog, N., Kihlberg, J. & Arnberg, N. (2007) Multivalent sialic acid conjugates inhibit adenovirus type 37 from binding to and infecting human corneal epithelial cells. Antiviral Res. 73, 92\u2013100.","cites":null},{"id":37505569,"title":"Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.","authors":[],"date":"2007","doi":null,"raw":"Lore, K., Adams, W.C., Havenga, M., Precopio, M.L., Holterman, L.,Goudsmit, J. & Koup, R. A. (2007). Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses. J Immunol 179,1721\u20131729.","cites":null},{"id":37505535,"title":"New Adenovirus Species Found in a Patient Presenting with Gastroenteritis.","authors":[],"date":"2007","doi":null,"raw":"Jones, M. S., Harrach, B., Ganac, R.D., Gozum, M.M.A., Cruz, W.P.D, Riedel, B., Pan, C., Delwart, E.L. & Schnurr, D.P. (2007). New Adenovirus Species Found in a Patient Presenting with Gastroenteritis. J.Virol. 81, 5978-5984.","cites":null},{"id":37505497,"title":"New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.","authors":[],"date":"1998","doi":null,"raw":"Fallaux, F.J., Bout, A., van der Velde, I., van den Wollenberg, D.J., Hehir, K.M., Keegan, J., Auger, C., Cramer, S.J., van Ormondt, H., van der Eb, A. J., Valerio, D. & Hoeben, R.C. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum.","cites":null},{"id":37505552,"title":"Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.","authors":[],"date":"1997","doi":null,"raw":"Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine 25, 2074\u20132084 Leppard, K.N. (1997). E4 gene function in adenovirus, adenovirus vector and adenoassociated virus infections. J. Gen. Virol. 78, 2131-2138.","cites":null},{"id":37505521,"title":"Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-crossreactivity with Ad5.","authors":[],"date":"2004","doi":null,"raw":"Holterman, L., Vogels, R., van der Vlugt, R., Sieuwerts, M., Grimbergen, J., Kaspers, J., Geelen, E., van der Helm, E., Lemckert, A., Gillissen, G., Verhaagh, S., Custers, J., Zuijdgeest, D., Berkhout, B., Bakker, M., Quax, P., Goudsmit, J & Havenga, M. (2004). Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-crossreactivity with Ad5. J. Virol. 78, 13207\u201313215.","cites":null},{"id":37505506,"title":"Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.","authors":[],"date":"2005","doi":null,"raw":"Goodfellow, J.A., Bowes, T., Sheikh, K., Odaka, M., Halstead, S.K., Humphreys, P.D., Wagner, E.R., Yuki, N., Furukawa, K., Furukawa, K., Plomp, J.J. & Willison, H.J. (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J. Neurosci. 25, 1620-1628 Goonetilleke, N., Moore, S., Dally, L., Winstone, N., Cebere, I., Mahmoud, A., Pinheiro, S., Gillespie, G., Brown, D., Loach, V., Roberts, J., Guimaraes-Walker, A., Hayes, P., Loughran, K., Smith, C., De Bont, J., Verlinde, C., Vooijs, D., Schmidt, C., Boaz, M., Gilmour, J., Fast, P., Dorrell, L., Hanke, T. & McMichael, A.J. (2006) Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J. Virol. 80, 4717\u20134728 Gorziglia, M.I., Lapcevich, C., Roy, S., Kang, Q., Kadan, M., Wu, V., Pechan, P. & Kaleko, M. (1999) Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. J. Virol. 73, 6048-6055 Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. (1977). Characterisics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.","cites":null},{"id":37505515,"title":"Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.","authors":[],"date":"1999","doi":null,"raw":"Hofmann, C., Loser, P., Cichon, G., Arnold, W., Both, G.W. & Strauss, M. (1999) Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo. J. Virol. 73, 6930\u20136936.","cites":null},{"id":37505494,"title":"Pathogenesis of pneumovirus infections in mice: detection ofpneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization.","authors":[],"date":"1998","doi":null,"raw":"Cook, P.M., Eglin, R.P. & Easton, A.J. (1998) Pathogenesis of pneumovirus infections in mice: detection ofpneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization. J. Gen. Virol. 79, 2411-2417 Condon, C., Watkins, S.C., Celluzzi, C.M., Thompson, K. And Falo, L.D. (1996) DNA-based immunisation by in vivo transfection of Dendritic cells. Nat. Med. 2, 1122-1128 Cox, J.H., Benninck, J.R. & Yewdell, J.W.  (1991)  Retention of Adenovirus E19 Glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation.  .J Exp. Med. 174, 1629-1637 Croyle, M.A., Le, H.T., Linse, K.D., Cerullo, V., Toietta, G., Beaudet, A. & Pastore, L. (2005). PEGylated helper-dependent adenoviral vectors: Highly efficient vectors with an enhanced safety profile. Gene Ther. 12, 579\u2013587.","cites":null},{"id":37505485,"title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.","authors":[],"date":"1999","doi":null,"raw":"& Colonna, M. (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5, 919-923 Cepko, C.L., Changelian, P.S. & Sharp, P.A. (1981). Immunoprecipitation with twodimensional pools as a hybridoma screening technique: production and characterisation of monoclonal antibodies against adenovirus 2 proteins.  Virology 110, 385-401.","cites":null},{"id":37505634,"title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.","authors":[],"date":"2010","doi":null,"raw":"Reyes-Sandoval, A., Berthoud, T., Alder, N., Siani, L., Gilbert, S.C., Nicosia, A., Colloca, S., Cortese, R. & Hill, A.V. (2010) Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infect. Immun. 78, 145-153 Reyes-Sandoval, A., Fitzgerald, J.C., Grant, R., Roy, S., Xiang, Z.Q., Li, Y., Gao, G.P., Wilson, J.M. & Ertl, H.C. (2004) Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J. Virol. 78, 7392-7399 Rice, S.A. & Klessig, D.F. (1985). Isolation and Analysis Of Adenovirus Type-5 Mutants Containing Deletions In the Gene Encoding the DNA-Binding Protein. J. Virol. 56, 767-778 Roberts, D.M., Nanda, A., Havenga, M.J., Abbink, P., Lynch, D.M., Ewald, B.A., Liu, J., Thorner, A.R., Swanson, P.E., Gorgone, D.A., Lifton, M.A., Lemckert, A.A., Holterman, L., Chen, B., Dilraj, A., Carville, A., Mansfield, K.G., Goudsmit, J. & Barouch, D.H. (2006). Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441, 239\u2013243.","cites":null},{"id":37505666,"title":"Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.","authors":[],"date":"2000","doi":null,"raw":"Trapani, J. A., Davis, J., Sutton, V.R. & Smyth, M.J. (2000). Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.  Curr. Op. Immunol. 12, 323-329.","cites":null},{"id":37505612,"title":"Progress and prospects: immune responses to viral vectors. Gene Ther.","authors":[],"date":"2010","doi":null,"raw":"Nayak, S. & Herzog, R.W. (2010) Progress and prospects: immune responses to viral vectors. Gene Ther. 17, 295-304 Nemerow, G.R., Pache, L., Reddy, V. & Stewart, P.L. (2009) Insights into adenovirus host cell interactions from structural studies. J. Virol. 384, 380-388 Newland, J.C. & Cooney, M.K. (1978) Characteristics of an adenovirus type 19 conjunctivitis isolate and evidence for a subgroup associated with epidemic conjunctivitis. Infection and Immunity 21, 303-309 Nicklin, S.A., Wu, E., Nemerow, G.R. & Baker, A.H. (2005) The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol. Ther. 12, 384-393 Nkolola, J.P., Wee, E.G.-T., Im, E.-J., Jewell, C.P., Chen, N., Xu, X.-N., McMichael, A.J. & Hanke, T. (2004). Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa. Gene Ther. 11, 1068\u20131080 Noda, M., Miyamoto, Y., Ikeda, Y., Matsuishi, T. & Ogino, T. (1991) Intermediate human adenovirus type 22\/H10,19,37 as a new etiological agent of conjunctivitis. J.","cites":null},{"id":37505477,"title":"Receptor for the group B coxsackieviruses and adenoviruses:","authors":[],"date":"2001","doi":null,"raw":"Carson, S.D. (2001) Receptor for the group B coxsackieviruses and adenoviruses: CAR. Rev. Med. Virol. 11, 29-226.","cites":null},{"id":37505657,"title":"Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A\/HK\/1\/68 (H3N2).","authors":[],"date":"2002","doi":null,"raw":"Tang, M., Harp, J.A. & Wesley, R.D. (2002) Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A\/HK\/1\/68 (H3N2). Arch. Virol. 147, 2125-2141 Tatsis, N. & Ertl, H.C.J. (2004). Adenoviruses as vaccine vectors. Mol. Ther. 10, 616-629 Thirion, C., Lochm\u00fcller, H., Ruzsics, Z., Boelhauve, M., K\u00f6nig, C., Thedieck, C., Kutik, S., Geiger, C., Kochanek, S., Volpers, C. and Burgert, H.G. (2006) Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum. Gene Ther. 17, 193-205 Thorpe, L.C. & Easton, A.J. (2005) Genome sequence of the non-pathogenic strain 15 of pneumonia virus of mice and comparison with the genome of the pathogenic strain J3666. J. Gen. Virol. 86, 159-169 Tollefson, A.E., Hermiston, T.W., Lichtenstein, D.L., Colle, C.F., Tripp, R.A., Dimitrov, T., Toth, K., Wells, C.E., Doherty, P.C. & Wold, W.S.M. (1998). Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392, 726-730.","cites":null},{"id":37505513,"title":"Recovery of new agent from patients with acute respiratory illness.","authors":[],"date":"1954","doi":null,"raw":"Hilleman, M., & Werner, J. (1954). Recovery of new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med. 85, 183-188.","cites":null},{"id":37505681,"title":"Recpetor usage of a newly emergent adenovirus type 14. Virology 387,","authors":[],"date":"2009","doi":null,"raw":"Wang, H., Tuve, S., Erdman, D.D. & Lieber, A. (2009) Recpetor usage of a newly emergent adenovirus type 14. Virology 387, 436-441 Wang, Y., Xiang, Z., Pasquini, S., & Ertl, H.C. (1997). The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. J. Virol. 71, 3677\u2013 3683.","cites":null},{"id":37505554,"title":"Regulated RNA processing and RNA transport during adenovirus infection. Seminars in Virology 8,","authors":[],"date":"1998","doi":null,"raw":"Leppard, K.N. (1998). Regulated RNA processing and RNA transport during adenovirus infection. Seminars in Virology 8, 301-307 Letellier, C., Boxus, M., Rosar, L., Toussaint, J.F., Walravens, K., Roels, S., Meyer, G., Letesson, J.J. & Kerkhofs, P. (2008) Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology. Vaccine 26, 4840-4848 Letvin, N.L. (2006) Progress and obstacles in the development of an AIDS vaccine.","cites":null},{"id":37505499,"title":"Replication-defective vector based on a chimpanzee adenovirus.","authors":[],"date":"2001","doi":null,"raw":"Microbiol. Rev. 13, 371\u2013384 Farina, S.F., Gao, G.P., Xiang, Z.Q., Rux, J.J., Burnett, R.M., Alvira, M.R., Marsh, J., Ertl, H.C. & Wilson, J.M. (2001) Replication-defective  vector based on a chimpanzee adenovirus. J. Virol. 75, 11603-11613 Fitzgerald, J.C., Gao, G.P., Reyes-Sandoval, A., Pavlakis, G.N., Xiang, Z.Q., Wlazlo, A.P., Giles-Davis, W., Wilson, J.M. & Ertl, H.C. (2003) A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J. Immunol. 170, 1416-1422 Flacher, V., Bouschbacher, M., Verronese, E., Massacrier, C., Sisirak, V., BerthierVergnes, O., de Saint-Vis, B., Caux, C., Dezutter-Dambuyant, C., Lebecque, S. & Valladeau, J. (2006) Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177, 7959\u2013 Flint, S.J., Enquist, L. W., Krug, R.M., Racaniello, V.R. & Skalka, A. M. (2000). Principles of virology: molecular biology, pathogenesis, and pontrol., 1 edn, pp. 803. Washington, DC: ASM Press.","cites":null},{"id":37505649,"title":"Replicationincompetent adenoviruses as vectors for protective immunization against measles virus infection.","authors":[],"date":"1994","doi":null,"raw":"Curr. Opin. Struct. Biol. 19, 507-514 Schindler, C., Fooks, A., Stephenson, J. & Liebert, U.G. (1994) Replicationincompetent adenoviruses as vectors for protective immunization against measles virus infection. Behring Inst. Mitt. 95, 109-115 Schneider-Brachert, W., Tchikov, V., Merkel, O., Jakob, M., Hallas, C., Kruse, M.L., Groiti, P., Lehn, A., Hildt, E., Held-Feindt, J., Dobner, T., Kabelitz, D., Kronke, M.","cites":null},{"id":37505430,"title":"Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1\/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.","authors":[],"date":"2006","doi":null,"raw":"Gene. Med. 8, 1300-1306 Becker, Y. (2006) Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1\/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review. Virus Genes 33, 235-252 Bell, S.D., Murray, E.S., Chang, R.S. & Snyder, J.C. (1959) Adenoviruses isolated from Saudi Arabia. I. Epidemiologic features. Am. J. Trop. Med. Hyg. 8, 492\u2013500 Bell, S.D., Rota, T.R. & McComb, D.E. (1960) Adenoviruses isolated from Saudi Arabia. II. Six new serotypes, Am. J. Trop. Med. Hyg. 9, 523\u2013526.","cites":null},{"id":37505498,"title":"Respiratory syncytial virus infection in adults.","authors":[],"date":"2000","doi":null,"raw":"Gene Ther. 9, 1909-1917 Falsey, R & Walsh, E.E. (2000) Respiratory syncytial virus infection in adults. Clin.","cites":null},{"id":37505673,"title":"Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis.","authors":[],"date":"1980","doi":null,"raw":"In: Granoff A, Webster RG, editors. Encyclopedia of virology, Vol. 1. New York: Academic Press. pp 1\u20137 Wadell, G. & de Jong, J.C. (1980) Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis. Infect. Immunol. 27, 292-296 Walters, R.W., Grunst, T., Bergelson, J.M., Finberg, R.W., Welsh, M.J. & Zabner, J.","cites":null},{"id":37505684,"title":"Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res.","authors":[],"date":"2005","doi":null,"raw":"Warming, S., Costantino, N., Court, D.L., Jenkins, N.A. & Copeland N.G. (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 24, 33-36 Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag, M.S., Komarova, N.L., Nowak, M.A., Hahn, B.H., Kwong, P.D. & Shaw, G.M. (2003) Antibody neutralization and escape by HIV-1. Nature 422, 307-312 Wilson, N.S., Behrens, G.M., Lundie, R.J., Smith, C.M., Waithman, J., Young, L., Forehan, S.P., Mount, A., Steptoe, R.J., Shortman, K.D., de Koning-Ward, T.F., Belz, G.T., Carbone, F.R., Crabb, B.S., Heath, W.R. & Villadangos, J.A. (2006) Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7, 165-172 Windheim, M. (2002) Characterization of the human adenovirus 19a E3\/49K Protein: a secreted lymphocyte binding factor with an immunomodulatory function. PhD thesis, Faculty of Chemistry and Pharmacy, Ludwig-Maximilian University of Munich, Germany.","cites":null},{"id":37505572,"title":"Specific gangliosides function as host cell receptors for Sendai virus.","authors":[],"date":"1981","doi":null,"raw":"Infect. Dis. 22, 143-147 Markwell, M.A., Svennerholm, L. & Paulson, J.C. (1981) Specific gangliosides function as host cell receptors for Sendai virus. PNAS 78, 5406-5410 Marttila, M., Persson, D., Gustafsson, D., Liszewski, M.K., Atkinson, J.P., Wadell, G. & Arnberg, N. (2005) CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. J. Virol. 79, 14429-14436 Mathias, P., Wickham, T., Moore, M. & Nemerwo, G. (1994) Multiple adenovirus serotypes use alpha v integrins for infection. J. Virol. 68, 6811-6814 Mathis, J.M. Stewart, P.L., Zhu, Z.B. & Curiel, D.T. (2006) Advanced generation Adenoviral virotherapy agents embody enhanced potency based upon CARindependent tropism. Clin. Can. Res. 12, 2651-2661 McDonald, D., Stockwin, L., Matzow, T., Zajdel, M.B. & Blair, G. (1999) Coxsaxkie and adenovius receptor (CAR)-dependent and major histocompatibility complex (MHC) class I18 independent uptake of recombinant adenoviruses into human tumour cells. Gene Ther. 6, 1512-1529 McElrath, M.J., De Rosa, S.C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O.D., Carter, D.K., Hural, J., Akondy, R., Buchbinder, S.P., Robertson, M.N., Mehrotra, D.V., Self, S.G., Corey, L., Shiver, J.W. & Casimiro, D.R. (2008).","cites":null},{"id":37505491,"title":"Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions.","authors":[],"date":"2001","doi":null,"raw":"Chiu, C.Y., Wu, E., Brown, S.L., Von Seggern, D.J., Nemerow, G.R. & Stewart, P.L. (2001) Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J. Virol. 75, 5375\u201380.","cites":null},{"id":37505622,"title":"Structural variations in species B adenovirus fibres impact CD46 association.","authors":[],"date":"2007","doi":null,"raw":"Pache, L., Venkataraman, S., Reddy, V.S. & Nemerow, G.R. Structural variations in species B adenovirus fibres impact CD46 association. J. Virol. 82, 7923\u20137931 Palese, P. & Shaw, M.J. (2007) Orthomyxoviridae: The viruses and their replication.","cites":null},{"id":37505441,"title":"Subversion of host defense mechanisms by adenoviruses.","authors":[],"date":"2002","doi":null,"raw":"Burgert, H-G., Ruzsics, Z., Obermeier, S., Hilgendorf, A., Windheim, M. & Elsing, A. (2002). Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol. Immunol.. 269, 273-318.","cites":null},{"id":37505660,"title":"The 10,400- and 14,500-Dalton proteins encoded by region E3 of Adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor.","authors":[],"date":"1991","doi":null,"raw":"Tollefson, A.E., Stewart, A.R., Yei, S., Saha, S.K., & Wold, W.S.M. (1991). The 10,400- and 14,500-Dalton proteins encoded by region E3 of Adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J. Virol. 65, 3095-3105.","cites":null},{"id":37505493,"title":"The coxsackie and adenovirus receptor is a transmembrane component of the tight junction.","authors":[],"date":"2001","doi":null,"raw":"Thromb. Vasc. Biol. 21, 238-242 Cohen, C.J., Shieh, J.T., Pickles, R., Okegawa, T., Hsieh, J. & Bergelson, J. (2001) The coxsackie and adenovirus receptor is a transmembrane component of the tight junction. PNAS 98, 15191-15196 Cohen, C.J., Xiang, Z.Q., Gao, G.P., Ertl, H.C., Wilson, J.M. & Bergelson, J.M. (2002) Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J. Gen. Virol. 83, 151-155 Collier, A.M., Connor, J.D. & Irving, W.R., Jr. (1966). Generalized type 5 adenovirus infection associated with the pertussis syndrome. J. Pediatr. 69, 1073-8.","cites":null},{"id":37505636,"title":"The coxsackie-adenovirus receptor protein can function as a cellular attachment protein from adenovirus serotypes from subgroups","authors":[],"date":"1998","doi":null,"raw":"Roelvink, P.W., Lizonova, A., Lee, J.G.M., Li, Y., Bergelson, J.M., Finberg, R.W., Brough, D.E., Kovesdi, I. & Wickham, T.J. (1998) The coxsackie-adenovirus receptor protein can function as a cellular attachment protein from adenovirus serotypes from subgroups A, C, D, E and F. J. Virol. 72, 7909-7916 Roelvink, P.W., Mi-Lee, G., Enfield, D.A., Kovesdi, I. & Wickham, T.J. (1999).","cites":null},{"id":37505432,"title":"The CTL\u2019s kiss of death.","authors":[],"date":"1995","doi":null,"raw":"Edited by Knipe, D.M. and Howley, P.M.  Philadelphia, Pa. Lippincott, Williams & Wilkins Berke, G. (1995) The CTL\u2019s kiss of death. Cell 81, 9-12 Berkner, K.L.  (1988). Development of adenovirus vectors for the expression of heterologous genes. BioTechniques. 6, 616\u2013629 Berlin, M.T. & Boulanger, P. (1993). Involvement of cellular adhesion seqiuences in the attachment of adenoviruses to the HeLa cell surface. J. Gen. Virol. 74, 1485-1497 Bertheau, P., Parquet, N., Ferchal, F., Gluckman, E. & Brocheriou, C. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation. Bone Marrow Trans. 17, 295-298 Bessis, N., GarciaCozar, F.J. & Boissier, M.C. (2004). Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther 11, S10\u2013S17 Bett, A.J., Haddara, W. Prevec, L. & Graham, F.L. (1994). An efficient andflexible system for construction of adenovirus vectors with insertions ordeletions in early regions 1 and 3. PNAS 91, 8802\u20138806 Bhardwaj, N., Young, J.W., Nisanian, A.J., Baggers, J. and Steinman, R.H. (1993) Small amounts of superantigen, when presented on dendritic cells are sufficient to initiate T cell responses. J. Exp. Med. 178, 633-42 Biery, M.C., Stewart, F.J., Stellwagen, A.E., Raleigh, E.A. & Craig, N.L. (2000). A simple in vitro Tn7-based transposition system with low target site selectivity for genome and gene analysis. Nucleic Acids Res. 28, 1067\u20131077 Bleackley, C.R. (2005) A molecular view of cytotoxic T lymphocyte induced killing.","cites":null},{"id":37505523,"title":"The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.","authors":[],"date":"1992","doi":null,"raw":"Holers, V.M., Kinoshita, T & Molina, H. (1992) The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.","cites":null},{"id":37505425,"title":"The influence of blood on in vivo adenovirus bio-distribution and transduction.","authors":[],"date":"2007","doi":null,"raw":"Baker, A.H., Mcvey, J.H., Waddington, S.N., Di Paolo, N.C. & Shayakhmetov, D.M. (2007) The influence of blood on in vivo adenovirus bio-distribution and transduction. Mol. Ther. 15, 1410\u20131416.","cites":null},{"id":37505433,"title":"The novel early region 3 protein E3\/49K is specifically expressed by adenoviruses of subgenus D: implications for epidemic keratoconjunctivitis and adenovirus evolution.","authors":[],"date":"2002","doi":null,"raw":"Biochem. Cell Biol. 83, 747-51 Blusch, J.H., Deryckere, F., Windheim, M., Ruzsics, Z., Arnberg, N., Adrian, T. & Burgert H-G. (2002) The novel early region 3 protein E3\/49K is specifically expressed by adenoviruses of subgenus D: implications for epidemic keratoconjunctivitis and adenovirus evolution. Virology 296, 94-106 Bonville, C.A., Easton, A.J., Rosenberg, H.F. & Domachowske, J.B. (2003). Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J. Virol. 77, 1237\u20131244 Borgland, S.L., Bowen, G.P., Wong, N.C., Libermann, T.A., & Muruve, D.A. (2000) Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J. Virol. 74, 3941\u20133947 Bridgeman, A., Roshorm, Y., Lockett, L.J., Xu, Z.Z., Hopkins, R., Shaw, J., Both, G.W., Hanke, T. (2009) Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine. Vaccine 28, 474-483 Brode, S., Macary, P.A. (2004) Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 112, 345-51 Brough, D.E., Hsu, C., Kulesa, V.A., Lee, G.M., Cantolupo, L.J., Lizonova, A. & Kovesdi, I. (1997). Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J. Virol. 71, 9206-9213 Brough, D.E., Lizonova, A., Hsu, C., Kulesa, V.A. & Kovesdi, I. (1996). A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70, 6497-501 Broughton, S. & Greenough, A. (2003) Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity, Expert Opin. Pharmacother. 4, 1801\u20131808 Brouwer, E., Havenga, M.J., Ophorst, O., de Leeuw, B., Gijsbers, L., Gillissen, G., Hoeben, R.C., ter Horst, M., Nanda, D., Dirven, C., Avezaat, C.J., Goudsmit, J. & Sillevis Smitt, P. (2007). Human adenovirus type 35 vector for gene therapy of brain cancer: Improved transduction and bypass of pre-existing anti-vector immunity in cancer patients. Cancer Gene. Ther. 14, 211\u2013219.","cites":null},{"id":37505639,"title":"The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.","authors":[],"date":"2005","doi":null,"raw":"Biol. Med. 110, 710-3 Rosenberg, H.F., Bonville, C.A., Easton, A.J. & Domachowske, J.B. (2005) The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol. Ther. 105, 1-6 Routes, J.M., Ryan, S., Morris, K., Takaki, R., Cerwenka, A. & Lanier, L.L. (2005).","cites":null},{"id":37505689,"title":"The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.","authors":[],"date":"1984","doi":null,"raw":"Microbiol. Immunol. 273, 29-85 Weiss, A., Wiskocil, R.L. & Stobo, J.D. (1984) The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133, 123-128 Wold, W.S.M., and Horwitz, M.S.(2007) Adenoviruses. In Fields Virology, 5 th edn.","cites":null},{"id":37505500,"title":"The Seattle Virus Watch. VII. Observations of adenovirus infections.","authors":[],"date":"1977","doi":null,"raw":"Fox, J., Hall, C., & Cooney, M. (1977). The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol 105, 362-86 Gaddum, R.M., Cook, R.S., Furze, J.M., Ellis, S.A. & Taylor, G. (2003) Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes Immunology 108, 220\u2013229 Gaggar, A., Shayakhmetov, D.M. & Lieber, A. (2003) CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9, 1408\u20131412 Gall, J.G., Crystal, R.G. & Falck-Pedersen, E. (1998). Construction and characterization of hexon-chimeric adenoviruses: Specification of adenovirus serotype. J. Virol. 72, 10260\u201310264 Garnett, C.T., Erdman, D., Xu, W. & Gooding, L.R. (2002) Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 76, 10608-10616 Garofalo, R., Kimpen, J.L., Welliver, R.C. & Ogra, P.L. (1992) Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120, 28\u201332 Garofalo, R.P., Patti, J., Hintz, K.A., Hill, V., Ogra, P.L. & Welliver, R.C. (2001) Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis J. Infect. Dis. 184, 393\u2013399 Gasser, S. & Raulet, D.H. (2006) Activation and self-tolerance of natural killer cells.","cites":null},{"id":37505645,"title":"Transposon-assisted cloning and traceless mutagenesis of Adenoviruses: Development of a novel vector based on species D.","authors":[],"date":"2006","doi":null,"raw":"Ruzsics, Z., Wagner, M., Osterlehner, A., Cook, J., Koszinowski, U. & Burgert, HG. (2006) Transposon-assisted cloning and traceless mutagenesis of Adenoviruses: Development of a novel vector based on species D. J. Virol. 80, 8100-8113 Saban, S.D., Nepomuceno, R.R., Gritton, L.D., Nemerow, G.R. & Stewart, P.L. (2005) CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells. J. Mol. Biol. 349, 526\u201337 Sailaja, G., HogenEsch, H., North, A., Hays, J. & Mittal, S.K. (2002) Encapsulation of recombinant adenovirus into alginate micro-spheres circumvents vector-specific immune response. Gene Ther. 9, 1722-1729.","cites":null},{"id":37505644,"title":"Update on structure and function.","authors":[],"date":"2009","doi":null,"raw":"Russell, W.C. (2009). Update on structure and function. J. Gen. Virol. 90, 1-20.","cites":null},{"id":37505492,"title":"Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer.","authors":[],"date":"2001","doi":null,"raw":"Chu, Y., Heistad, D., Cybulsky, M.I. & Davidson, B.L. (2001) Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer. Arterioscler.","cites":null},{"id":37505530,"title":"Viral vectors for dendritic cell based immunotherapy. Trends in Immunol.","authors":[],"date":"2001","doi":null,"raw":"Jenne, L., Schuler, G. & Steinkassrer, A. (2001) Viral vectors for dendritic cell based immunotherapy. Trends in Immunol. 22, 102-107 Jernigan, J.A., Lowry, B.S., Hayden, F.G., Kyger, S.A., Conway, B.P., Groschel, D.H.M. & Farr, B.M. (1993). Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: Risk factors and control. J. Infect. Dis. 167, 1307\u20131313 Jiang, W., Swiggard, W.J., Heufler, C., Peng, M., Mirza, A., Steinman, R.M. and Nussenzweig, M.C. (1995) The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-5 Johansson, C., Jonsson, M., Marttila, M., Persson, D., Fan, X.L., Skog, J., Fr\u00e4ngsmyr, L., Wadell, G. & Arnberg, N. (2007) Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J. Virol. 81, 954-963 Johansson, S.M., Arnberg, N., Elofsson, M., Wadell, G. & Kihlberg, J. (2005) Multivalent HAS conjugates of 3\u2019-sialyllactose are potent inhibitors of adenoviral cell attachment and infection. Chembiochem 6, 358\u2013364.","cites":null}],"documentType":{"type":1}},"contributors":[],"datePublished":null,"abstract":"Adenoviruses (Ads) have many attractive characteristics for use as agents of genebased\\ud\nvaccines and therapies. The most frequently used Ad vectors in preclinical\\ud\nresearch are based on Ad5. However, in the clinical setting Ad5 vectors have severe\\ud\nlimitations. About 90% of the population have neutralising antibodies against Ad5\\ud\nand infection requires expression of the viral receptor CAR, which is not present on\\ud\nimportant cell types. Previous data from this laboratory suggested that the species D\\ud\nadenovirus, Ad19a, may overcome some of these limitations. Most relevant for\\ud\nvaccination is its high efficiency of infection of human dendritic cells (DCs), the\\ud\nmost important antigen presenting cells. This highly effective DC targeting was\\ud\nretained in Ad19aGFP vectors. To investigate the potential of Ad19a vectors for\\ud\nvaccination further, two transgenes, the nucleocapsid gene from pneumovirus of\\ud\nmice (PVM-N), and a HIV polyprotein cassette (HIVA), were inserted into\\ud\nreplication-deficient Ad5 and Ad19a vectors using recombineering. rAd19aPVM and\\ud\nrAd19aHIVA expressed a significantly higher amount of transgene compared with\\ud\ntheir Ad5 homologues. Encouraging results were obtained when the ability of\\ud\nrAd5PVM and rAd19aPVM to protect mice from lethal PVM challenge was\\ud\nexamined using various prime\/boost vaccinations. A dose of 106 pfu of rAd19aPVM,\\ud\nbut not rAd5PVM, provided protection. rAd5PVM did, however, protect mice at the\\ud\nsame dose when combined with rAd19aPVM in a heterologous prime boost\\ud\nschedule. Vaccination-induced IgG responses to PVM-N did not correlate with\\ud\nprotection, implicating cell-mediated immune responses in protection. Utilising\\ud\nrAd19aGFP, evidence is also provided that Ad19a may use CD46 and to some extent\\ud\nCAR as a receptor on CHO cells, expanding our knowledge of the basic biology of\\ud\nthis virus","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":null,"rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:wrap.warwick.ac.uk:34601<\/identifier><datestamp>\n      2015-10-27T16:33:30Z<\/datestamp><setSpec>\n      7374617475733D756E707562<\/setSpec><setSpec>\n      7375626A656374733D51:5152:5152333535<\/setSpec><setSpec>\n      74797065733D746865736973<\/setSpec><setSpec>\n      636F6C6C656374696F6E3D77726170<\/setSpec><\/header><metadata><rioxx xmlns=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/\" xmlns:ali=\"http:\/\/ali.niso.org\/2014\/ali\/1.0\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:dcterms=\"http:\/\/purl.org\/dc\/terms\/\" xmlns:rioxxterms=\"http:\/\/docs.rioxx.net\/schema\/v2.0\/rioxxterms\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/ http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/rioxx.xsd\" ><ali:free_to_read>\n    \n      <\/ali:free_to_read><dc:description>Adenoviruses (Ads) have many attractive characteristics for use as agents of genebased\\ud\nvaccines and therapies. The most frequently used Ad vectors in preclinical\\ud\nresearch are based on Ad5. However, in the clinical setting Ad5 vectors have severe\\ud\nlimitations. About 90% of the population have neutralising antibodies against Ad5\\ud\nand infection requires expression of the viral receptor CAR, which is not present on\\ud\nimportant cell types. Previous data from this laboratory suggested that the species D\\ud\nadenovirus, Ad19a, may overcome some of these limitations. Most relevant for\\ud\nvaccination is its high efficiency of infection of human dendritic cells (DCs), the\\ud\nmost important antigen presenting cells. This highly effective DC targeting was\\ud\nretained in Ad19aGFP vectors. To investigate the potential of Ad19a vectors for\\ud\nvaccination further, two transgenes, the nucleocapsid gene from pneumovirus of\\ud\nmice (PVM-N), and a HIV polyprotein cassette (HIVA), were inserted into\\ud\nreplication-deficient Ad5 and Ad19a vectors using recombineering. rAd19aPVM and\\ud\nrAd19aHIVA expressed a significantly higher amount of transgene compared with\\ud\ntheir Ad5 homologues. Encouraging results were obtained when the ability of\\ud\nrAd5PVM and rAd19aPVM to protect mice from lethal PVM challenge was\\ud\nexamined using various prime\/boost vaccinations. A dose of 106 pfu of rAd19aPVM,\\ud\nbut not rAd5PVM, provided protection. rAd5PVM did, however, protect mice at the\\ud\nsame dose when combined with rAd19aPVM in a heterologous prime boost\\ud\nschedule. Vaccination-induced IgG responses to PVM-N did not correlate with\\ud\nprotection, implicating cell-mediated immune responses in protection. Utilising\\ud\nrAd19aGFP, evidence is also provided that Ad19a may use CD46 and to some extent\\ud\nCAR as a receptor on CHO cells, expanding our knowledge of the basic biology of\\ud\nthis virus.<\/dc:description><dc:format>application\/pdf<\/dc:format><dc:identifier>http:\/\/wrap.warwick.ac.uk\/34601\/1\/WRAP_THESIS_Martin_2010.pdf<\/dc:identifier><dc:language>en<\/dc:language><dc:subject>QR355<\/dc:subject><dc:title>The potential of a novel Adenovirus vector for vaccination<\/dc:title><rioxxterms:author>Martin, Stuart<\/rioxxterms:author><rioxxterms:type>Thesis<\/rioxxterms:type><rioxxterms:version>NA<\/rioxxterms:version><\/rioxx><\/metadata><\/record>","journals":null,"language":{"code":"en","id":9,"name":"English"},"relations":[],"year":null,"topics":["QR355"],"subject":["QR355"],"fullText":""}